Side-delivered transcatheter heart valve replacement

The invention relates to a transcatheter heart valve replacement (A61F2/2412), and in particular to a side delivered large diameter, low profile transcatheter prosthetic valve having a compressible tubular frame having a side wall and a central axial lumen, said tubular frame having a height of 8-20 mm and a diameter of 40-80 mm, an atrial sealing cuff, a subannular anchoring component, and aa flow control component comprising a leaflet structure, wherein the valve is side-delivered longitudinally to a mitral valve annulus or tricuspid valve annulus of a patient using a 22-34 Fr delivery catheter.

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description
CROSS-REFERENCE TO RELATED APPLICATIONS

Provided by Application Data Sheet per USPTO rules.

STATEMENT REGARDING FEDERALLY SPONSORED R&D

Provided by Application Data Sheet per with USPTO rules.

NAMES OF PARTIES TO JOINT RESEARCH AGREEMENT

Provided by Application Data Sheet per with USPTO rules.

REFERENCE TO SEQUENCE LISTING

Provided by Application Data Sheet per USPTO rules.

STATEMENT RE PRIOR DISCLOSURES

Provided by Application Data Sheet per USPTO rules.

BACKGROUND OF THE INVENTION Field of the Invention

The invention relates to a transcatheter heart valve replacement (A61F2/2412).

DESCRIPTION OF THE RELATED ART

In 1952 surgeons implanted the first mechanical heart valve. This first valve was a ball valve and it was designed by Dr. Charles Hufnagel. The recipient of this valve was a 30-year-old woman who could lead a normal life after the surgery. However, one downside of this design was that it could only be placed in the descending aorta instead of the heart itself. For this reason it did not fully correct the valve problem, only alleviate the symptoms. However it was a significant achievement because it proved that synthetic materials could be used to create heart valves.

In 1960, a new type of valve was invented and was successfully implanted. This valve is the Starr-Edwards ball valve, named after its originators. This valve was a modification of Hufnagel's original valve. The ball of the valve was slightly smaller and caged from both sides so it could be inserted into the heart itself.

The next development was tilting disc technology which was introduced in the late 1960s. These valves were a great improvement over the ball designs. The tilting dic technology allowed blood to flow in a more natural way while reducing damage to blood cells from mechanical forces. However, the struts of these valves tended to fracture from fatigue over time. As of 2003, more than 100,000 Omniscience and 300,000 Hall-Kaster/Medtronic-Hall tilting disc valves were implanted with essentially no mechanical failure.

In 1977, bi-leaflet heart valves were introduced by St. Jude. Similar to a native heart valve, blood flows directly through the center of the annulus of pyrolytic carbon valves mounted within nickel-titanium housing which makes these valves superior to other designs. However, a downside of this design is that it allows some regurgitation. A vast majority of mechanical heart valves used today have this design. As of 2003, more than 1.3 million St. Jude valves were deployed and over 500,000 Carbomedics valves with no failures to leaflets or housing. It should be noted that the human heart beats about 31 million times per year. Development continues with compressible valves that are delivered via a catheter instead of requiring the trauma and complications of open heart surgery. This means that a cardiologist trained in endoscopy can, in theory, deploy a heart valve replacement during an outpatient procedure. However, transcatheter valves are often delivered by perforating the apex of the heart to access the ventricle, and the perforation is often used to anchor an annular valve replacement.

Additionally, a problem with stent-style replacement valves is that they often continue to have the regurgitation or leakage problems of prior generations of valves, as well as require expensive materials engineering in order to cope with the 100's of millions of cycles encountered during just a few years of normal heart function. Accordingly, there is still a need for alternative and simpler solutions to addressing valve-related heart pathologies.

BRIEF SUMMARY OF THE INVENTION

Accordingly, the present invention is directed to a side delivered transcatheter prosthetic valve comprising:

a compressible tubular frame having a side wall and a central axial lumen, said tubular frame having a height of 8-20 mm and a diameter of 40-80 mm,

an atrial sealing cuff attached to a top edge of the side wall,

a subannular anchoring component attached to the tubular frame, said subannular anchoring component selected from one or more of the group consisting of a lower tension arm extending from a distal side of the tubular frame, a proximal anchoring tab extending from a proximal side of the tubular frame, a ventricular sealing collar attached to a bottom edge of the side wall, and at least one tissue anchor to connect the tubular frame to native tissue, and

a flow control component comprising a leaflet structure having three leaflets of pericardial material sewn to a leaflet frame to form a rounded cylinder mounted within the lumen of the tubular frame and configured to permit blood flow in a first direction through an inflow end of the valve and block blood flow in a second direction, opposite the first direction, through an outflow end of the valve,

wherein the valve is compressible to a compressed configuration for introduction into the body using a delivery catheter for implanting at a mitral valve annulus or tricuspid valve annulus of a patient, said delivery catheter having an internal diameter from 22 Fr (7.33 mm) to 34 Fr (11.33 mm),

said compressed configuration having a long-axis that is substantially parallel to a length-wise cylindrical axis of the delivery catheter, and substantially orthogonal to the blood flow through the flow control component mounted in the central axial lumen,

said compressed configuration having a height and a width to fit within the delivery catheter, the height and width of the compressed configuration compressed by longitudinal/length-wise rolling or folding,

wherein the valve is expandable to an expanded configuration having a long-axis substantially orthogonal to the blood flow through the flow control component mounted in the central axial lumen,

said tubular frame and said atrial sealing cuff having a polyester cover, and said tubular frame and said atrial sealing cuff made from superelastic shape-memory material selected from Ni—Ti alloy, Cu—Zn—Al—Ni alloys, Cu—Al—Ni alloys, a polymer composite, a composite containing one or more of carbon nanotubes, carbon fibers, metal fibers, glass fibers, and polymer fibers, a stainless steel, a cobalt chromium material, and a titanium material.

In another preferred embodiment, there is provided a side delivered transcatheter prosthetic valve wherein the at least one tissue anchor to connect the tubular frame to native tissue is an anterior leaflet clip or anchor, a posterior leaflet clip or anchor, or a septal leaflet clip or anchor.

In another preferred embodiment, there is provided a side delivered transcatheter prosthetic valve wherein said tubular frame is comprised of a braided, wire, or laser-cut wire frame, and said tubular frame is covered with a biocompatible material.

In another preferred embodiment, there is provided a side delivered transcatheter prosthetic valve wherein the tubular frame has a side profile of a flat cone shape having a diameter R of 40-80 mm, a diameter r of 20-60 mm, and a height of 8-20 mm.

In another preferred embodiment, there is provided a side delivered transcatheter prosthetic valve wherein the tubular frame has an inner surface and an outer surface, said inner surface and said outer surface covered with pericardial tissue.

In another preferred embodiment, there is provided a side delivered transcatheter prosthetic valve wherein the tubular frame has a side profile of an hourglass shape having a top diameter R1 of 40-80 mm, a bottom diameter R2 of 50-70 mm, an internal diameter r of 20-60 mm, and a height of 8-20 mm.

In another preferred embodiment, there is provided a side delivered transcatheter prosthetic valve wherein the flow control component has an internal diameter of 20-60 mm and a height of 8-20 mm.

In another preferred embodiment, there is provided a side delivered transcatheter prosthetic valve wherein the flow control component is supported with one or more longitudinal supports integrated into or mounted upon the flow control component, the one or more longitudinal supports selected from rigid or semi-rigid posts, rigid or semi-rigid ribs, rigid or semi-rigid battons, rigid or semi-rigid panels, and combinations thereof.

In another preferred embodiment, there is provided a side delivered transcatheter prosthetic valve wherein the tension arm extending from the distal side of the tubular frame is comprised of wire loop or wire frame, integrated frame section, or stent, and extend from about 10-40 mm away from the tubular frame.

In another preferred embodiment, there is provided a side delivered transcatheter prosthetic valve wherein the valve also comprises (i) an upper tension arm attached to a distal upper edge of the tubular frame, the upper tension arm comprised of wire loop or wire frame extending from about 2-20 mm away from the tubular frame, and (ii) the lower tension arm extending from the distal side of the tubular frame is comprised of wire loop or wire frame, integrated frame section, or stent, and extends from about 10-40 mm away from the tubular frame.

The present invention is also directed to a method for side delivery of implantable prosthetic valve between a ventricle and an atrium of a heart, the method comprising the steps:

    • advancing a delivery catheter containing the valve described and claimed herein in a compressed configuration to the atrium of the heart,
    • and
    • partially releasing the valve from the delivery catheter to position the distal side wall of the tubular frame at an oblique angle against a distal portion of the native annulus and allowing blood to flow from the atrium to the ventricle both through the native valve and through the prosthetic valve,
    • releasing the remainder of the prosthetic valve from the

delivery catheter to an expanded configuration to assess valve function at the oblique angle before seating the valve completely into the native annulus,

pushing a proximal side wall of the tubular frame into the native annulus to complete seating of the valve in the native annulus, wherein said atrial sealing cuff is disposed on the atrial floor and the tubular frame is seated within the native annulus, and

anchoring the subannular anchoring component of the valve to native annular or subannular tissue,

    • wherein the native valve is a tricuspid valve or a mitral

valve.

In another preferred embodiment, there is provided a method for side delivery of implantable prosthetic valve between a ventricle and an atrium of a heart wherein releasing the valve from the delivery catheter is selected from the steps consisting of: (i) pulling the valve out of the delivery catheter using a rigid elongated pushing rod that is releasably connected to the distal side of the valve, wherein advancing the pushing rod away from the delivery catheter pulls the compressed valve out of the delivery catheter, or (ii) pushing the valve out of the delivery catheter using a rigid elongated pushing rod that is releasably connected to the proximal side of the valve, wherein advancing the pushing rod out of from the delivery catheter pushes the compressed valve out of the delivery catheter.

In another preferred embodiment, there is provided a method for side delivery of implantable prosthetic valve between a ventricle and an atrium of a heart comprising the additional step of anchoring one or more tissue anchors attached to the valve into native tissue.

In another preferred embodiment, there is provided a method for side delivery of implantable prosthetic valve between a ventricle and an atrium of a heart wherein the subannular anchoring component is a lower tension arm extending from a distal side of the tubular frame.

In another preferred embodiment, there is provided a method for side delivery of implantable prosthetic valve between a ventricle and an atrium of a heart comprising the additional step of rotating the heart valve prosthesis using a steerable catheter along an axis parallel to the plane of the valve annulus, wherein an upper tension arm mounted on the valve is conformationally pressure locked against supra-annular tissue, and wherein a lower tension arm mounted on the valve is conformationally pressure locked against sub-annular tissue.

In another preferred embodiment, there is provided a side delivered transcatheter prosthetic valve comprising: (i) a tubular frame having a flow control component mounted within the tubular frame and configured to permit blood flow in a first direction through an inflow end of the valve and block blood flow in a second direction, opposite the first direction, through an outflow end of the valve, wherein the valve is compressible to a compressed configuration for introduction into the body using a delivery catheter, and expandable to an expanded configuration for implanting at a desired location in the body, wherein the valve is compressible and expandable along a long-axis substantially parallel to a cylindrical axis of the delivery catheter, and wherein the valve has a height of about 5-60 mm and a diameter of about 25-80 mm.

In another preferred embodiment, there is provided a side delivered transcatheter prosthetic valve wherein the tubular frame forms a two part framework, a first part comprises a flared atrial cuff joined to a second part that comprises cylindrical member, wherein the cuff is joined to the cylindrical member around the circumference of a top edge of the cylindrical member.

In another preferred embodiment, there is provided a side delivered transcatheter prosthetic valve wherein said tubular frame is comprised of a braid, wire, or laser-cut wire frame, and said tubular frame is covered with a biocompatible material.

In another preferred embodiment, there is provided a side delivered transcatheter prosthetic valve wherein the tubular frame has a side profile of a flat cone shape having a diameter R of 40-80 mm, a diameter r of 20-40 mm, and a height of 10-20 mm.

In another preferred embodiment, there is provided a side delivered transcatheter prosthetic valve wherein the tubular frame has an inner surface and an outer surface, said inner surface covered with a biocompatible material comprising pericardial tissue, and said outer surface covered with a biocompatible material comprising a woven synthetic polyester material.

In another preferred embodiment, there is provided a side delivered transcatheter prosthetic valve wherein the tubular frame has a side profile of an hourglass flat conical shape having a top diameter R1 of 40-80 mm, a bottom diameter R2 of 50-70 mm, an internal diameter r of 20-30 mm, and a height of 5-60 mm.

In another preferred embodiment, there is provided a side delivered transcatheter prosthetic valve wherein the valve in an expanded configuration has a central tube axis that is substantially parallel to the first direction.

In another preferred embodiment, there is provided a side delivered transcatheter prosthetic valve wherein the flow control component has an internal diameter of 20-30 mm and a height of 20-40 mm, and a plurality of leaflets of pericardial material joined to form a rounded cylinder at an inflow end and having a flat closable aperture at an outflow end.

In another preferred embodiment, there is provided a side delivered transcatheter prosthetic valve wherein the flow control component is supported with one or more longitudinal supports integrated into or mounted upon the flow control component, the one or more longitudinal supports selected from rigid or semi-rigid ribs, rigid or semi-rigid battons, rigid or semi-rigid panels, and combination thereof.

In another preferred embodiment, there is provided a side delivered transcatheter prosthetic valve comprising a tension arm extending from a distal side of the tubular frame, the tension arm comprised of wire loop or wire frame extending from about 10-40 mm away from the tubular frame.

In another preferred embodiment, there is provided a side delivered transcatheter prosthetic valve comprising (i) an upper tension arm attached to a distal upper edge of the tubular frame, the upper tension arm comprised of wire loop or wire frame extending from about 2-20 mm away from the tubular frame, and (ii) a lower tension arm extending from a distal side of the tubular frame, the lower tension arm comprised of wire loop or wire frame extending from about 10-40 mm away from the tubular frame.

In another preferred embodiment, there is provided a side delivered transcatheter prosthetic valve comprising at least one tissue anchor connected to the tubular frame for engaging annular tissue.

In another preferred embodiment, there is provided a method for side delivery of implantable prosthetic valve to a desired location in the body, the method comprising the steps: (i) advancing a delivery catheter to the desired location in the body and delivering an expandable prosthetic valve to the desired location in the body by releasing the valve from the delivery catheter, wherein the valve comprises a tubular frame having a flow control component mounted within the tubular frame and configured to permit blood flow in a first direction through an inflow end of the valve and block blood flow in a second direction, opposite the first direction, through an outflow end of the valve, wherein the valve is compressible to a compressed configuration for introduction into the body using a delivery catheter, and expandable to an expanded configuration for implanting at a desired location in the body, wherein the valve is compressible and expandable along a long-axis substantially parallel to a cylindrical axis of the delivery catheter, wherein the valve has a height of about 5-60 mm and a diameter of about 25-80 mm.

In another preferred embodiment, there is provided a method for side delivery of implantable prosthetic valve wherein releasing the valve from the delivery catheter comprises pulling the valve out of the delivery catheter using a rigid elongated pushing rod that is releasably connected to the distal side of the valve, wherein advancing the pushing rod away from the delivery catheter pulls the compressed valve out of the delivery catheter.

In another preferred embodiment, there is provided a method for side delivery of implantable prosthetic valve comprising the additional step of anchoring one or more tissue anchors attached to the valve into annular tissue.

In another preferred embodiment, there is provided a method for side delivery of implantable prosthetic valve comprising the additional step of positioning a tension arm of the heart valve prosthesis into the right ventricular outflow tract of the right ventricle.

In another preferred embodiment, there is provided a method for side delivery of implantable prosthetic valve comprising the additional steps of positioning a lower tension arm of the heart valve prosthesis into the right ventricular outflow tract of the right ventricle, and positioning an upper tension arm into a supra-annular position, the upper tension arm connected to the lower tension arm, and the upper tension arm providing a supra-annular downward force in the direction of the ventricle and lower tension arm providing a sub-annular upward force in the direction of the atrium.

In another preferred embodiment, there is provided a method for side delivery of implantable prosthetic valve comprising the the additional step of rotating the heart valve prosthesis using a steerable catheter along an axis parallel to the plane of the valve annulus, wherein an upper tension arm mounted on the valve is conformationally pressure locked against supra-annular tissue, and wherein a lower tension arm mounted on the valve is conformationally pressure locked against sub-annular tissue.

In another preferred embodiment, there is provided a method for loading an implantable prosthetic valve into a delivery catheter, the method comprising the steps: (i) attaching a pulling wire to a sidewall of an implantable prosthetic valve and pulling the valve into a tapering fixture or funnel, wherein the valve comprises a tubular frame having a flow control component mounted within the tubular frame and configured to permit blood flow in a first direction through an inflow end of the valve and block blood flow in a second direction, opposite the first direction, through an outflow end of the valve, wherein pulling the valve into a tapering fixture or funnel compresses the valve to a compressed configuration for loading into a delivery catheter, wherein the valve is compressible and expandable along a long-axis substantially parallel to a cylindrical axis of the delivery catheter, wherein the valve has a height of about 5-60 mm and a diameter of about 25-80 mm.

BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF DRAWINGS

FIG. 1 is an illustration of a plan view of a heart valve prosthesis according to the present invention with a valve frame having a distal upper and lower tension arm mounted on, and anchored to, the anterior leaflet side of the native annulus, and having a mechanical anchor element, e.g. surgical tissue screw, anchored on a posterior or septal side of the native annulus.

FIG. 2 is an illustration of a plan view of a heart valve prosthesis according to the present invention with a valve frame having a distal upper and lower tension arm mounted on, and anchored to, the anterior leaflet side of the native annulus, and having a mechanical anchor element, e.g. proximal sealing cuff, for anchoring on the posterior and septal side of the native annulus.

FIG. 3 is an illustration of a plan view of a heart valve prosthesis according to the present invention with a valve frame having a distal upper and lower tension arm mounted on, and anchored to, the anterior leaflet side of the native annulus, and having a mechanical anchor element, e.g. hourglass annular seal, for anchoring on the posterior and/or septal side of the native annulus.

FIG. 4 is an illustration of a PLAN view of a low-profile, e.g. 10 mm in height, wire loop embodiment of the heart valve prosthesis having an annulus support loop and an upper and lower tension arm formed as a unitary or integral part, and covered with a biocompatible material.

FIG. 5 is an illustration of a TOP view of a low-profile, e.g. 10 mm in height, wire loop embodiment of the heart valve prosthesis having an annulus support loop, an upper and lower tension arm formed as a unitary or integral part, an inner two-panel conical valve sleeve, and covered with a biocompatible material.

FIG. 6 is an illustration of a BOTTOM view of a low-profile, e.g. 10 mm in height, wire loop embodiment of the heart valve prosthesis having an annulus support loop, an upper and lower tension arm formed as a unitary or integral part, an inner two-panel conical valve sleeve, and covered with a biocompatible material.

FIG. 7 is an illustration of a compressed and elongated wire loop embodiment of the heart valve prosthesis disposed within a delivery catheter and having an annulus support loop and an upper and lower tension arm formed as a unitary or integral part.

FIG. 8 is an illustration of a compressed and elongated wire loop embodiment of the heart valve prosthesis partially ejected, and partially disposed within, a delivery catheter and having an annulus support loop and an upper and lower tension arm formed as a unitary or integral part.

FIG. 9 is an illustration of a plan view of a heart valve prosthesis partially mounted within the valve annulus.

FIG. 10 is an illustration of a plan view of a heart valve prosthesis completely seated within the valve annulus.

FIG. 11 is an illustration of a plan view of a native right atrium of a human heart, and shows the superior vena cava (SVC), the inferior vena cava (IVC), the right atrium (RA), the tricuspid valve and annulus (TCV), the anterior leaflet (A), the posterior leaflet (P), the septal leaflet(S), the right ventricle (RV), and the right ventricular outflow tract (RVOT).

FIG. 12 is an illustration of a heart valve prosthesis having a wire-frame according to the present invention being delivered to tricuspid valve annulus.

FIG. 13 is an illustration of a heart valve prosthesis having a wire-frame according to the present invention being delivered to tricuspid valve annulus.

FIG. 14 is an illustration of a heart valve prosthesis having a wire-frame according to the present invention that has been delivered to tricuspid valve annulus.

FIG. 15 is an illustration of a heart valve prosthesis having a braided/laser cut-frame according to the present invention being delivered to tricuspid valve annulus.

FIG. 16 is an illustration of a heart valve prosthesis having a braided/laser cut-frame according to the present invention being delivered to tricuspid valve annulus.

FIG. 17 is an illustration of a heart valve prosthesis having a braided/laser cut-frame according to the present invention that has been delivered to tricuspid valve annulus.

FIG. 18 is an illustration of a heart valve prosthesis according to the present invention being delivered to tricuspid valve annulus and shows step 1 in a valve assessment process.

FIG. 19 is an illustration of a heart valve prosthesis according to the present invention being delivered to tricuspid valve annulus, and shows Step 2 in a valve assessment process.

FIG. 20 is an illustration of a heart valve prosthesis according to the present invention that has been delivered to tricuspid valve annulus, and shows Step 3 in a valve assessment process.

FIG. 21 is an illustration of a wire-frame embodiment of a heart valve prosthesis according to the present invention in a compressed, intra-catheter phase.

FIG. 22 is an illustration of a profile, or plan, view of a wire-frame embodiment of the heart valve prosthesis according to the present invention in a un-compressed, post-catheter-ejection phase.

FIG. 23 is an illustration of a profile, or plan, view of a braided or laser-cut frame embodiment of the heart valve prosthesis according to the present invention in a un-compressed, post-catheter-ejection phase.

FIG. 24 is an illustration of a TOP view of a heart valve prosthesis according to the present invention having covered wire loops for the upper tension arm(s).

FIG. 25 is an illustration of a PLAN view of a heart valve prosthesis according to the present invention having a wire loop construction for the upper and lower tension arms.

FIG. 26 is an illustration of a CUT-AWAY PLAN view of a heart valve prosthesis according to the present invention, and shows the inner panel valve sleeve mounted within the inner space defined by the tubular frame.

FIG. 27 is an illustration of a BOTTOM view of a heart valve prosthesis according to the present invention having covered wire loops for the lower tension arm.

FIG. 28 is an illustration of a TOP view of a heart valve prosthesis according to the present invention having braid or laser-cut wire frame for the upper tension arm(s).

FIG. 29 is an illustration of a PLAN view of a heart valve prosthesis according to the present invention having braid or laser-cut wire frame construction for the upper and lower tension arms.

FIG. 30 is an illustration of a CUT-AWAY PLAN view of a braid or laser-cut embodiment of the heart valve prosthesis according to the present invention, and shows the inner panel valve sleeve mounted within the inner space defined by the tubular frame.

FIG. 31 is an illustration of a BOTTOM view of a heart valve prosthesis according to the present invention having braid or laser-cut wire frame for the lower tension arm.

FIG. 32 is an illustration of a heart valve prosthesis according to the present invention having a wire loop construction for the tubular frame, with two vertical support posts extending down the edge on opposing sides of the valve sleeve. During compression into the delivery catheter, the posts are engineered to fold horizontally during compression, and to elastically unfold during ejection to deploy the valve sleeve.

FIG. 33 is an illustration of a CUT-AWAY PLAN view of a heart valve prosthesis according to the present invention, and shows a two-post embodiment of the inner panel valve sleeve mounted within the inner space defined by the tubular frame.

FIG. 34 is an illustration of a CUT-AWAY PLAN view of a heart valve prosthesis according to the present invention, and shows a three-panel, three-post embodiment of the inner panel valve sleeve mounted within the inner space defined by the tubular frame.

FIG. 35 is an illustration of a heart valve prosthesis according to the present invention having a braid or laser-cut construction for the tubular frame, with a valve sleeve that extends beyond the bottom of the tubular frame.

FIG. 36 is an illustration of a heart valve prosthesis having a braid or laser-cut tubular frame and extended valve sleeve compressed within a delivery catheter.

FIG. 37 is an illustration of a heart valve prosthesis having a braid or laser-cut tubular frame and extended valve sleeve shown partially compressed within a delivery catheter, and partially ejected from the delivery catheter.

FIG. 38 is an illustration of a heart valve prosthesis having a braid or laser-cut tubular frame and extended valve sleeve engaging the tissue on the anterior side of the native annulus with the curved distal side-wall of the tubular frame sealing around the native annulus.

FIG. 39 is an illustration of a heart valve prosthesis having a braid or laser-cut tubular frame and extended valve sleeve engaging the tissue on the anterior side of the native annulus with the curved distal side-wall of the tubular frame sealing around the native annulus, and with the proximal side-wall tension-mounted into the posterior side of the native annulus.

FIG. 40 is an illustration of a TOP view of a heart valve prosthesis according to the present invention having braid or laser-cut wire frame and shown mounted within a cross-sectional view of the atrial floor at the annulus.

FIG. 41 is an illustration of a BOTTOM view of a heart valve prosthesis according to the present invention having braid or laser-cut wire frame for a lower tension arm and shown mounted within a cross-sectional view of the ventricular ceiling at the annulus.

FIG. 42 is an illustration of a PLAN view of an embodiment of the prosthetic valve shown in a compressed configuration within a delivery catheter.

FIG. 43 is an illustration of a cross-sectional view of one embodiment of a compressed valve within a delivery catheter.

FIG. 44 is an illustration of a cross-sectional view of another embodiment of a compressed valve within a delivery catheter.

FIG. 45 is an illustration of a cross-sectional view of one embodiment of the prosthetic valve.

FIG. 46 (a)-(b)-(c) is an illustration of a sequence of a low-profile valve being rolled into a configuration for placement within a delivery catheter.

FIG. 47 is an illustration of an END-VIEW of a low-profile valve that has been longitudinally rolled and loaded within a delivery catheter.

FIG. 48 is an illustration of a rotational lock embodiment of the present invention where the prosthetic valve is delivered to the native annulus with an off-set sub-annular tension arm/tab positioned below the native annulus, and an off-set supra-annular tension arm/tab positioned above the native annulus, while the tubular frame is partially rolled off-set from the annular plane along a longitudinal axis.

FIG. 49 is an illustration of a rotational lock embodiment of the present invention where the prosthetic valve is delivered to the native annulus with an off-set sub-annular tension arm/tab positioned below the native annulus, and an off-set supra-annular tension arm/tab positioned above the native annulus, while the tubular frame is rolled into functional position parallel to the annular plane.

FIG. 50 is an illustration of a low-profile, e.g. 8-20 mm, side-delivered prosthetic valve shown deployed into the native annulus.

FIG. 51 is an illustration of a low-profile, e.g. 8-20 mm, side-delivered prosthetic valve shown compressed or housed within the delivery catheter.

FIG. 52 is an illustration of a low-profile, e.g. 8-20 mm, side-delivered prosthetic valve shown ejected from the delivery catheter and positioned against the anterior side of the native annulus.

FIG. 53 is an illustration of a open cross-section view of a low-profile, side-delivered prosthetic valve and shows the inner valve sleeve.

FIG. 54 is an illustration of a two-panel embodiment of an inner valve sleeve.

FIG. 55 is an illustration of one embodiment of an inner valve sleeve having two rigid support posts.

FIG. 56 is an illustration of a three-panel embodiment of an inner valve sleeve.

FIG. 57 is an illustration of a three-panel embodiment of an inner valve sleeve having three rigid support posts.

FIG. 58 is a flowchart describing one set of method steps for delivery of a low-profile, side-delivered prosthetic valve.

FIG. 59 a-b-c is a series of illustrations of a plan view of a tissue anchor having a floating radio-opaque marker. 59a shows the tissue anchor accessing the annular tissue with the radio-opaque marker at the distal end of the anchor and in contact with the atrial surface of the annular tissue. 59b shows the tissue anchor advancing into the annular tissue with the radio-opaque marker threaded onto the tissue anchor and maintaining position on the atrial surface of the annular tissue. 59c shows the tissue anchor completely advanced into the annular tissue such that the tissue anchor and the threaded floating marker are now adjacent, indicating the desired depth, tension, and/or plication of the tissue anchor with respect to the annular tissue.

FIG. 60 is an illustration of a plan view of of a tissue anchor having a straight thread and a constant pitch.

FIG. 61 is an illustration of a plan view of of a tissue anchor having a straight thread and a variable pitch.

FIG. 62 is an illustration of a plan view of of a tissue anchor having a tapered thread and a constant pitch.

FIG. 63 is an illustration of a plan view of of a tissue anchor having a sunken taper thread and a variable pitch.

FIG. 64 is an illustration of Step 1 of a 4 step process for clipping a low profile valve to annular tissue, as shown here in a non-limiting example of clipping to a proximal or anterior side of the native annulus. FIG. 64 shows a low profile valve being inserted into the valve annulus and low profile valve having an integral anchor delivery conduit or channel with an anchor disposed in the lumen of the channel and an anchor delivery catheter attached to the anchor.

FIG. 65 is an illustration of Step 2 of a 4 step process for clipping a low profile valve to annular tissue, as shown here in a non-limiting example of clipping to a proximal or anterior side of the native annulus. FIG. 65 shows a low profile valve completely deployed within the valve annulus and an integral anchor delivery conduit or channel with an anchor disposed in the lumen of the channel and an anchor delivery catheter attached to the anchor.

FIG. 66 is an illustration of Step 3 of a 4 step process for clipping a low profile valve to annular tissue, as shown here in a non-limiting example of clipping to a proximal or anterior side of the native annulus. FIG. 66 shows the anchor being pushed out of the lumen of the delivery conduit or channel and into the annular tissue.

FIG. 67 is an illustration of Step 4 of a 4 step process for clipping a low profile valve to annular tissue, as shown here in a non-limiting example of clipping to a proximal or anterior side of the native annulus. FIG. 67 shows the anchor in a locked position after being pushed out of the lumen of the delivery conduit or channel and into the annular tissue, thus anchoring the proximal side of the low profile valve.

FIG. 68 is an illustration of Step 1 of a 5 step process for clipping a low profile valve to annular tissue, as shown here in a non-limiting example of clipping to a proximal or anterior side of the native annulus. FIG. 68 shows catheter delivery of an attachment wire with the clip housed within the lumen of the clip delivery catheter.

FIG. 69 is an illustration of Step 2 of a 5 step process for clipping a low profile valve to annular tissue, as shown here in a non-limiting example of clipping to a proximal or anterior side of the native annulus. FIG. 69 shows the clip delivery catheter inserted into an intra-annular space and shows an attachment wire and shows the clip housed within the lumen of the clip delivery catheter.

FIG. 70 is an illustration of Step 3 of a 5 step process for clipping a low profile valve to annular tissue, as shown here in a non-limiting example of clipping to a proximal or anterior side of the native annulus. FIG. 70 shows a receiver element ejected from the delivery catheter and positioned behind tissue to be captured.

FIG. 71 is an illustration of Step 4 of a 5 step process for clipping a low profile valve to annular tissue, as shown here in a non-limiting example of clipping to a proximal or anterior side of the native annulus. FIG. 71 shows an anchor element piercing the annular tissue and inserting into a receiver element.

FIG. 72 is an illustration of Step 5 of a 5 step process for clipping a low profile valve to annular tissue, as shown here in a non-limiting example of clipping to a proximal or anterior side of the native annulus. FIG. 72 shows that the clip delivery catheter is withdrawn and the anchor element and receiver element are connected to the annular tissue and a also connected by connector wire to the low profile valve.

FIG. 73 is an illustration of one embodiment of a partial cut-away interior view of a tri-leaflet embodiment of a low-profile, e.g. 8-20 mm, side-delivered prosthetic valve.

FIG. 74 is an illustration of another embodiment of a partial cut-away interior view of a tri-leaflet embodiment of a low-profile, e.g. 8-20 mm, side-delivered prosthetic valve.

FIG. 75 is an illustration of a top view of a tri-leaflet embodiment of a low-profile, e.g. 8-20 mm, side-delivered prosthetic valve.

FIG. 76 is an illustration of the trans-septal (femoral-IVC) delivery of a low-profile, e.g. 8-20 mm, side-delivered prosthetic MITRAL valve shown partially housed within the delivery catheter, and partially ejected for deployment into the native mitral annulus.

FIG. 77 is an illustration of a low-profile, e.g. 8-20 mm, side-delivered prosthetic MITRAL valve shown housed within the delivery catheter.

FIG. 78 is an illustration of a low-profile, e.g. 8-20 mm, side-delivered prosthetic MITRAL valve shown partially housed within a delivery catheter and partially latterally ejected from the delivery catheter and positioned for deployment against the anterior side of the native mitral annulus.

FIG. 79 is an illustration of a low-profile, e.g. 8-20 mm, side-delivered prosthetic MITRAL valve shown ejected from the delivery catheter and positioned against the anterior side of the native mitral annulus.

FIG. 80 is an illustration of a side or plan view of a low-profile, e.g. 8-20 mm, side-delivered prosthetic valve shown deployed into the native MITRAL annulus.

 DETAILED DESCRIPTION OF THE INVENTION

The invention is directed to a transcatheter heart valve replacement that is a low profile, orthogonally delivered (side delivered) implantable prosthetic valve having an ring-shaped tubular frame, an inner 2- or 3-panel sleeve, an elongated sub-annular tension arm extending into the right ventricular outflow tract, and one or more anchor elements.

The embodiments herein and the various features and advantageous details thereof are explained more fully with reference to the non-limiting embodiments that are illustrated in the accompanying drawings and detailed in the following description. Descriptions of well-known components and processing techniques are omitted so as to not unnecessarily obscure the embodiments herein. The examples used herein are intended merely to facilitate an understanding of ways in which the embodiments herein may be practiced and to further enable those of skill in the art to practice the embodiments herein. Accordingly, the examples should not be construed as limiting the scope of the embodiments herein.

Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. Like numbers refer to like elements throughout. As used herein the term “and/or” includes any and all combinations of one or more of the associated listed items.

The terminology used herein is for the purpose of describing particular embodiments only and is not intended to limit the full scope of the invention. As used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises” and/or “comprising,” when used in this specification, specify the presence of stated features, integers, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, and/or groups thereof.

Unless defined otherwise, all technical and scientific terms used herein have the same meanings as commonly understood by one of ordinary skill in the art. Nothing in this disclosure is to be construed as an admission that the embodiments described in this disclosure are not entitled to antedate such disclosure by virtue of prior invention. As used in this document, the term “comprising” means “including, but not limited to.”

Many modifications and variations can be made without departing from its spirit and scope, as will be apparent to those skilled in the art. Functionally equivalent methods and apparatuses within the scope of the disclosure, in addition to those enumerated herein, will be apparent to those skilled in the art from the foregoing descriptions. Such modifications and variations are intended to fall within the scope of the appended claims. The present disclosure is to be limited only by the terms of the appended claims, along with the full scope of equivalents to which such claims are entitled. It is to be understood that this disclosure is not limited to particular methods, reagents, compounds, compositions or biological systems, which can, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting.

With respect to the use of substantially any plural and/or singular terms herein, those having skill in the art can translate from the plural to the singular and/or from the singular to the plural as is appropriate to the context and/or application. The various singular/plural permutations may be expressly set forth herein for sake of clarity.

It will be understood by those within the art that, in general, terms used herein, and especially in the appended claims (e.g., bodies of the appended claims) are generally intended as “open” terms (e.g., the term “including” should be interpreted as “including but not limited to,” the term “having” should be interpreted as “having at least,” the term “includes” should be interpreted as “includes but is not limited to,” etc.). It will be further understood by those within the art that virtually any disjunctive word and/or phrase presenting two or more alternative terms, whether in the description, claims, or drawings, should be understood to contemplate the possibilities of including one of the terms, either of the terms, or both terms. For example, the phrase “A or B” will be understood to include the possibilities of “A” or “B” or “A and B.”

In addition, where features or aspects of the disclosure are described in terms of Markush groups, those skilled in the art will recognize that the disclosure is also thereby described in terms of any individual member or subgroup of members of the Markush group.

As will be understood by one skilled in the art, for any and all purposes, such as in terms of providing a written description, all ranges disclosed herein also encompass any and all possible subranges and combinations of subranges thereof. Any listed range can be easily recognized as sufficiently describing and enabling the same range being broken down into at least equal subparts. As will be understood by one skilled in the art, a range includes each individual member.

Definitions

Orthogonal or Side-Delivery

In the description and claims herein, the term “orthogonal” or “side-delivered” or “side-delivery” is used to describe that the valves of the present invention are compressed and delivered at a roughly 90 degree angle compared to traditional transcatheter heart valves. Traditional valves have a central cylinder axis that is parallel to the length-wise axis of the delivery catheter and are deployed from the end of the delivery catheter in a manner akin to pushing a closed umbrella out of a sleeve. The valves of the present invention are compressed and delivered in a sideways manner. Traditional valves can only be expanded as large as what the internal diameter of the delivery catheter will allow. Efforts to increase the expanded diameter of traditional valves have run into the problems of trying to compress too much material and structure into too little space. Mathematically, the term orthogonal refers to an intersecting angle of 90 degrees between two lines or planes. As used, herein the term “substantially orthogonal” refers to an intersecting angle ranging from 75 to 105 degrees. The intersecting angle or orthogonal angle refers to both (i) the relationship between the length-wise cylindrical axis of the delivery catheter and the long-axis of the compressed valve of the invention, where the long-axis is perpendicular to the central cylinder axis of traditional valves, and (ii) the relationship between the long-axis of the compressed or expanded valve of the invention and the axis defined by the blood flow through the prosthetic valve where the blood is flowing, eg. from one part of the body or chamber of the heart to another downstream part of the body or chamber of the heart, such as from an atrium to a ventricle through a native annulus.

Transcatheter

In the description and claims herein, the term “transcatheter” is used to define the process of accessing, controlling, and delivering a medical device or instrument within the lumen of a catheter that is deployed into a heart chamber, as well as an item that has been delivered or controlled by such as process. Transcatheter access is known to include via femoral artery and femoral vein, via brachial artery and vein, via carotid and jugular, via intercostal (rib) space, and via sub-xyphoid. Transcatheter can be synonymous with transluminal and is functionally related to the term “percutaneous” as it relates to delivery of heart valves.

Tubular Frame

In the description and claims herein, the term “tubular frame”, and also “wire frame” or “flange or “collar” refers to a three-dimensional structural component that is seated within a native valve annulus and is used as a mounting element for a leaflet structure, a flow control component, or a flexible reciprocating sleeve or sleeve-valve.

Tubular Frame Structure

The tubular frame can be a ring, or cylindrical or conical tube, made from a durable, biocompatible structural material such as Nitinol or similar alloy, wherein the tubular frame is formed by manufacturing the structural material as a braided wire frame, a laser-cut wire frame, or a wire loop. The tubular frame is about 5-60 mm in height, has an outer diameter dimension, R, of 30-80 mm, and an inner diameter dimension of 31-79 mm, accounting for the thickness of the wire material itself. As stated, the tubular frame can have a side-profile of a ring shape, cylinder shape, conical tube shape, but may also have a side profile of a flat-cone shape, an inverted flat-cone shape (narrower at top, wider at bottom), a concave cylinder (walls bent in), a convex cylinder (walls bulging out), an angular hourglass, a curved, graduated hourglass, a ring or cylinder having a flared top, flared bottom, or both. In one preferred embodiment, the tubular frame used in the prosthetic valve deployed in the tricuspid annulus may have a complex shape determined by the anatomical structures where the valve is being mounted. For example, in the tricuspid annulus, the circumference of the tricuspid valve may be a rounded ellipse, the septal wall is known to be substantially vertical, and the tricuspid is known to enlarge in disease states along the anterior-posterior line. Accordingly, a prosthetic valve may start in a roughly tubular configuration, and be heat-shaped to provide an upper atrial cuff or flange for atrial sealing and a lower trans-annular tubular section having an hourglass cross-section for about 60-80% of the circumference to conform to the native annulus along the posterior and anterior annular segments while remaining substantially vertically flat along 20-40% of the annular circumference to conform to the septal annular segment.

Tubular Frame Covering

The tubular frame is optionally internally or externally covered, partially or completely, with a biocompatible material such as pericardium. The tubular frame may also be optionally externally covered, partially or completely, with a second biocompatible material such as polyester or Dacron®.

Tubular Frame Purpose

The tubular frame has a central axial lumen where a prosthetic valve or flow-control structure, such as a reciprocating compressible sleeve, is mounted across the diameter of the lumen. The tubular frame is also tensioned against the inner aspect of the native annulus and provides structural patency to a weakened annular ring.

Tubular Frame Optional Collars

The tubular frame may optionally have a separate atrial collar attached to the upper (atrial) edge of the frame, for deploying on the atrial floor, that is used to direct blood from the atrium into the sleeve and to seal against blood leakage around the tubular frame. The tubular frame may also optionally have a separate ventricular collar attached to the lower (ventricular) edge of the frame, for deploying in the ventricle immediately below the native annulus that is used to prevent regurgitant leakage during systole, to prevent dislodging of the device during systole, to sandwich or compress the native annulus or adjacent tissue against the atrial collar, and optionally to attach to and support the sleeve/conduit.

Tubular Frame Delivery

The tubular frame may be compressed for transcatheter delivery and may be expandable as a self-expandable shape-memory element or using a transcatheter expansion balloon. Some embodiments may have both an atrial collar and a ventricular collar, whereas other embodiments within the scope of the invention include prosthetic valves having either a single atrial collar, a single ventricular collar, or having no additional collar structure.

Flow Control Component

In the description and claims herein, the term “flow control component” refers in a non-limiting sense to a leaflet structure having 2-, 3-, 4-leaflets of flexible biocompatible material such a treated or untreated pericardium that is sewn or joined to a tubular frame, to function as a prosthetic valve. Such a valve can be a heart valve, such as a tricuspid, mitral, aortic, or pulmonary, that is open to blood flowing during diastole from atrium to ventricle, and that closes from systolic ventricular pressure applied to the outer surface. Repeated opening and closing in sequence can be described as “reciprocating”.

Tissue Anchor

In the description and claims herein, the term “tissue anchor” or “plication tissue anchor” or “secondary tissue anchor”, or “dart” or “pin” refers to a fastening device that connects the upper atrial frame to the the native annular tissue, usually at or near the periphery of the collar. The anchor may be positioned to avoid piercing tissue and just rely on the compressive force of the two plate-like collars on the captured tissue, or the anchor, itself or with an integrated securement wire, may pierce through native tissue to provide anchoring, or a combination of both. The anchor may have a specialized securement mechanism, such as a pointed tip with a groove and flanged shoulder that is inserted or popped into a mated aperture or an array of mated apertures that allow the anchor to attach, but prevent detachment when the aperture periphery locks into the groove near the flanged shoulder. The securement wire may be attached or anchored to the collar opposite the pin by any attachment or anchoring mechanisms, including a knot, a suture, a wire crimp, a wire lock having a cam mechanism, or combinations.

Support Post

The term “support post” refers to a rigid or semi-rigid length of material such as Nitinol or PEEK, that may be mounted on a spoked frame and that runs axially, or down the center of, or within a sewn seam of—, the flexible sleeve. The sleeve may be unattached to the support post, or the sleeve may be directly or indirectly attached to the support post.

In the description that follows, the term “body channel” is used to define a blood conduit or vessel within the body. Of course, the particular application of the prosthetic heart valve determines the body channel at issue. An aortic valve replacement, for example, would be implanted in, or adjacent to, the aortic annulus. Likewise, a tricuspid or mitral valve replacement will be implanted at the tricuspid or mitral annulus. Certain features of the present invention are particularly advantageous for one implantation site or the other. However, unless the combination is structurally impossible, or excluded by claim language, any of the heart valve embodiments described herein could be implanted in any body channel.

The term “lumen” refers to the inside of a cylinder tube. The term “bore” refers to the inner diameter.

Displacement—The volume of fluid displaced by one complete stroke or revolution

Ejection fraction is a measurement of the percentage of blood leaving your heart each time it contracts. During each heartbeat pumping cycle, the heart contracts and relaxes. When your heart contracts, it ejects blood from the two pumping chambers (ventricles)

As a point of further definition, the term “expandable” is used herein to refer to a component of the heart valve capable of expanding from a first, delivery diameter to a second, implantation diameter. An expandable structure, therefore, does not mean one that might undergo slight expansion from a rise in temperature, or other such incidental cause. Conversely, “non-expandable” should not be interpreted to mean completely rigid or a dimensionally stable, as some slight expansion of conventional “non-expandable” heart valves, for example, may be observed.

Force—A push or pull acting upon a body. In a hydraulic cylinder, it is the product of the pressure on the fluid, multiplied by the effective area of the cylinder piston.

Prosthetic Valve

The term prosthesis or prosthetic encompasses both complete replacement of an anatomical part, e.g. a new mechanical valve replaces a native valve, as well as medical devices that take the place of and/or assist, repair, or improve existing anatomical parts, e.g. native valve is left in place. For mounting within a passive assist cage, the invention contemplates a wide variety of (bio)prosthetic artificial heart valves. Contemplated as within the scope of the invention are ball valves (e.g. Starr-Edwards), bileaflet valves (St. Jude), tilting disc valves (e.g. Bjork-Shiley), stented pericardium heart-valve prosthesis' (bovine, porcine, ovine) (Edwards line of bioprostheses, St. Jude prosthetic valves), as well as homograft and autograft valves. For bioprosthetic pericardial valves, it is contemplated to use bioprosthetic aortic valves, bioprosthetic mitral valves, bioprosthetic tricuspid valves, and bioprosthetic pulmonary valves.

Frame Material

Preferably, the frame is made from superelastic metal wire, such as Nitinol™ wire or other similarly functioning material. The material may be used for the frame/stent, for the collar, and/or for anchors. It is contemplated as within the scope of the invention to use other shape memory alloys such as Cu—Zn—Al—Ni alloys, Cu—Al—Ni alloys, as well as polymer composites including composites containing carbon nanotubes, carbon fibers, metal fibers, glass fibers, and polymer fibers. It is contemplated that the frame may be constructed as a braid, wire, or laser cut wire frame. Such materials are available from any number of commercial manufacturers, such as Pulse Systems. Laser cut wire frames are preferably made from Nickel-Titanium (Nitinol™), but also without limitation made from stainless steel, cobalt chromium, titanium, and other functionally equivalent metals and alloys, or Pulse Systems braided frame that is shape-set by heat treating on a fixture or mandrel.

One key aspect of the frame design is that it be compressible and when released have the stated property that it return to its original (uncompressed) shape. This requirement limits the potential material selections to metals and plastics that have shape memory properties. With regards to metals, Nitinol has been found to be especially useful since it can be processed to be austenitic, martensitic or super elastic. Martensitic and super elastic alloys can be processed to demonstrate the required compression features.

Laser Cut

One possible construction of the wire frame envisions the laser cutting of a thin, isodiametric Nitinol tube. The laser cuts form regular cutouts in the thin Nitinol tube. In one preferred embodiment, the Nitinol tube expands to form a three-dimensional structure formed from diamond-shaped cells. The structure may also have additional functional elements, e.g. loops, anchors, etc. for attaching accessory components such as biocompatible covers, tissue anchors, releasable deployment and retrieval control guides, knobs, attachments, rigging, and so forth.

Secondarily the tube is placed on a mold of the desired shape, heated to the Martensitic temperature and quenched. The treatment of the wire frame in this manner will form a device that has shape memory properties and will readily revert to the memory shape at the calibrated temperature.

Braided Wire

A frame can be constructed utilizing simple braiding techniques. Using a Nitinol wire—for example a 0.012″ wire—and a simple braiding fixture, the wire is wound on the braiding fixture in a simple over/under braiding pattern until an isodiametric tube is formed from a single wire. The two loose ends of the wire are coupled using a stainless steel or Nitinol coupling tube into which the loose ends are placed and crimped. Angular braids of approximately 60 degrees have been found to be particularly useful. Secondarily, the braided wire frame is placed on a shaping fixture and placed in a muffle furnace at a specified temperature to set the wire frame to the desired shape and to develop the martensitic or super elastic properties desired.

Tethers—The tethers are made from surgical-grade materials such as biocompatible polymer suture material. Non-limiting examples of such material include ultra high-molecular weight polyethylene (UHMWPE), 2-0 exPFTE(polytetrafluoroethylene) or 2-0 polypropylene. In one embodiment the tethers are inelastic. It is also contemplated that one or more of the tethers may optionally be elastic to provide an even further degree of compliance of the valve during the cardiac cycle.

Tines—Anchors—Tines/Barbs

The device can be seated within the valvular annulus through the use of tines or barbs. These may be used in conjunction with, or in place of one or more tethers. The tines or barbs are located to provide attachment to adjacent tissue. Tines are forced into the annular tissue by mechanical means such as using a balloon catheter. In one non-limiting embodiment, the tines may optionally be semi-circular hooks that upon expansion of the wire frame body, pierce, rotate into, and hold annular tissue securely. Anchors are deployed by over-wire delivery of an anchor or anchors through a delivery catheter. The catheter may have multiple axial lumens for delivery of a variety of anchoring tools, including anchor setting tools, force application tools, hooks, snaring tools, cutting tools, radio-frequency and radiological visualization tools and markers, and suture/thread manipulation tools. Once the anchor(s) are attached, tensioning tools may be used to adjust the length of tethers that connect to an implanted valve to adjust and secure the implant as necessary for proper functioning. It is also contemplated that anchors may be spring-loaded and may have tether-attachment or tether-capture mechanisms built into the tethering face of the anchor(s). Anchors may also have in-growth material, such as polyester fibers, to promote in-growth of the anchors into the myocardium.

In one embodiment, where a prosthetic valve may or may not include a ventricular collar, the anchor or dart is not attached to a lower ventricular collar, but is attached directly into annular tissue or other tissue useful for anchoring.

Tube and/or Cover Material—Biological Tissue—

The tissue used herein is a biological tissue that is a chemically stabilized pericardial tissue of an animal, such as a cow (bovine pericardium) or sheep (ovine pericardium) or pig (porcine pericardium) or horse (equine pericardium). Preferably, the tissue is bovine pericardial tissue. Examples of suitable tissue include that used in the products Duraguard®, Peri-Guard®, and Vascu-Guard®, all products currently used in surgical procedures, and which are marketed as being harvested generally from cattle less than 30 months old. Other patents and publications disclose the surgical use of harvested, biocompatible animal thin tissues suitable herein as biocompatible “jackets” or sleeves for implantable stents, including for example, U.S. Pat. No. 5,554,185 to Block, U.S. Pat. No. 7,108,717 to Design & Performance-Cyprus Limited disclosing a covered stent assembly, U.S. Pat. No. 6,440,164 to Scimed Life Systems, Inc. disclosing a bioprosthetic valve for implantation, and U.S. Pat. No. 5,336,616 to LifeCell Corporation discloses acellular collagen-based tissue matrix for transplantation.

Polymers

In one preferred embodiment, the conduit may optionally be made from a synthetic material such a polyurethane or polytetrafluoroethylene.

Where a thin, durable synthetic material is contemplated, e.g. for a covering, synthetic polymer materials such expanded polytetrafluoroethylene or polyester may optionally be used. Other suitable materials may optionally include thermoplastic polycarbonate urethane, polyether urethane, segmented polyether urethane, silicone polyether urethane, silicone-polycarbonate urethane, and ultra-high molecular weight polyethylene. Additional biocompatible polymers may optionally include polyamides, polyolefins, polyesters, elastomers, polyethylene-glycols, polyethersulphones, polysulphones, polyvinylpyrrolidones, polyvinylchlorides, other fluoropolymers, silicone polyesters, siloxane polymers and/or oligomers, and/or polylactones, and block co-polymers using the same.

Polyamides (PA)

PA is an early engineering thermoplastic invented that consists of a “super polyester” fiber with molecular weight greater than 10,000. It is commonly called Nylon. Application of polyamides includes transparent tubing's for cardiovascular applications, hemodialysis membranes, and also production of percutaneous transluminal coronary angioplasty (PTCA) catheters.

Polyolefin

Polyolefins include polyethylene and polypropylene are the two important polymers of polyolefins and have better biocompatibility and chemical resistance. In cardiovascular uses, both low-density polyethylene and high-density polyethylene are utilized in making tubing and housings. Polypropylene is used for making heart valve structures.

Polyesters

Polyesters includes polyethylene-terephthalate (PET), using the name Dacron. It is typically used as knitted or woven fabric for vascular grafts. Woven PET has smaller pores which reduces blood leakage and better efficiency as vascular grafts compared with the knitted one. PET grafts are also available with a protein coating (collagen or albumin) for reducing blood loss and better biocompatibility [39]. PET vascular grafts with endothelial cells have been searched as a means for improving patency rates. Moreover, polyesters are widely preferred material for the manufacturing of bioabsorbable stents. Poly-L-lactic acids (PLLA), polyglycolic acid (PGA), and poly(D, L-lactide/glycolide) copolymer (PDLA) are some of the commonly used bioabsorbable polymers.

Polytetrafluoroethylene

Polytetrafluoroethylene (PTFE) is synthetic fluorocarbon polymer with the common commercial name of Teflon by Dupont Co. Common applications of PTFE in cardiovascular engineering include vascular grafts and heart valves. PTFE sutures are used in the repair of mitral valve for myxomatous disease and also in surgery for prolapse of the anterior or posterior leaflets of mitral valves. PTFE is particularly used in implantable prosthetic heart valve rings. It has been successfully used as vascular grafts when the devices are implanted in high-flow, large-diameter arteries such as the aorta. Problem occurs when it is implanted below aortic bifurcations and another form of PTFE called elongated-PTFE (e-PTFE) was explored. Expanded PTFE is formed by compression of PTFE in the presence of career medium and finally extruding the mixture. Extrudate formed by this process is then heated to near its glass transition temperature and stretched to obtain microscopically porous PTFE known as e-PTFE. This form of PTFE was indicated for use in smaller arteries with lower flow rates promoting low thrombogenicity, lower rates of restenosis and hemostasis, less calcification, and biochemically inert properties.

Polyurethanes

Polyurethane has good physiochemical and mechanical properties and is highly biocompatible which allows unrestricted usage in blood contacting devices. It has high shear strength, elasticity, and transparency. Moreover, the surface of polyurethane has good resistance for microbes and the thrombosis formation by PU is almost similar to the versatile cardiovascular biomaterial like PTFE. Conventionally, segmented polyurethanes (SPUs) have been used for various cardiovascular applications such as valve structures, pacemaker leads and ventricular assisting device.

Covered Wire Frame Materials

Drug-eluting wire frames are contemplated for use herein. DES basically consist of three parts: wire frame platform, coating, and drug. Some of the examples for polymer free DES are Amazon Pax (MINVASYS) using Amazonia CroCo (L605) cobalt chromium (Co—Cr) wire frame with Paclitaxel as an antiproliferative agent and abluminal coating have been utilized as the carrier of the drug. BioFreedom (Biosensors Inc.) using stainless steel as base with modified abluminal coating as carrier surface for the antiproliferative drug Biolimus A9. Optima (CID S.r.I.) using 316 L stainless steel wire frame as base for the drug Tacrolimus and utilizing integrated turbostratic carbofilm as the drug carrier. VESTA sync (MIV Therapeutics) using GenX stainless steel (316 L) as base utilizing microporous hydroxyapatite coating as carrier for the drug Sirolimus. YUKON choice (Translumina) used 316 L stainless steel as base for the drugs Sirolimus in combination with Probucol.

Biosorbable polymers may also be used herein as a carrier matrix for drugs. Cypher, Taxus, and Endeavour are the three basic type of bioabsorbable DES. Cypher (J&J, Cordis) uses a 316 L stainless steel coated with polyethylene vinyl acetate (PEVA) and polybutyl methacrylate (PBMA) for carrying the drug Sirolimus. Taxus (Boston Scientific) utilizes 316 L stainless steel wire frames coated with translute Styrene Isoprene Butadiene (SIBS) copolymer for carrying Paclitaxel which elutes over a period of about 90 days. Endeavour (Medtronic) uses a cobalt chrome driver wire frame for carrying zotarolimus with phosphorylcholine as drug carrier. BioMatrix employing S-Wire frame (316 L) stainless steel as base with polylactic acid surface for carrying the antiproliferative drug Biolimus. ELIXIR-DES program (Elixir Medical Corp) consisting both polyester and polylactide coated wire frames for carrying the drug novolimus with cobalt-chromium (Co—Cr) as base. JACTAX (Boston Scientific Corp.) utilized D-lactic polylactic acid (DLPLA) coated (316 L) stainless steel wire frames for carrying Paclitaxel. NEVO (Cordis Corporation, Johnson & Johnson) used cobalt chromium (Co—Cr) wire frame coated with polylactic-co-glycolic acid (PLGA) for carrying the drug Sirolimus.

Examples of preferred embodiments of the reciprocating pressure conduit valve include the following details and features.

Example

One preferred embodiment of a side delivered transcatheter prosthetic valve has a tubular frame with a flow control component mounted within the tubular frame and configured to permit blood flow in a first direction through an inflow end of the valve and block blood flow in a second direction, opposite the first direction, through an outflow end of the valve, wherein the valve is compressible to a compressed configuration for introduction into the body using a delivery catheter for implanting at a desired location in the body, said compressed configuration having a long-axis oriented at an intersecting angle of between 45-135 degrees to the first direction, and expandable to an expanded configuration having a long-axis oriented at an intersecting angle of between 45-135 degrees to the first direction, wherein the long-axis of the compressed configuration of the valve is substantially parallel to a length-wise cylindrical axis of the delivery catheter,

wherein the valve has a height of about 5-60 mm and a diameter of about 25-80 mm. Importantly, this heart valve substitute does not have a traditional valve configuration, can be delivered to the heart using the inferior vena cava (IVC/femoral transcatheter delivery pathway compressed within a catheter, and expelled from the catheter to be deployed without open heart surgery.

Example

In another preferred embodiment of a transcatheter valve, comprises: a cylindrical tubular frame having a height of about 5-60 mm and an outer diameter of about 25-80 mm, said tubular frame comprised of a braid, wire, or laser-cut wire frame having a substantially circular central aperture, said tubular frame partially covered with a biocompatible material; a collapsible flow control component disposed within the central aperture, said sleeve having a height of about 5-60 mm and comprised of at least two opposing leaflets that provide a reciprocating closable channel from a heart atrium to a heart ventricle; an upper tension arm attached to a distal upper edge of the tubular frame, the upper tension arm comprised of stent, segment of tubular frame, wire loop or wire frame extending from about 10-30 mm away from the tubular frame; a lower tension arm extending from a distal side of the tubular frame, the lower tension arm comprised of stent, segment of tubular frame, wire loop or wire frame extending from about 10-40 mm away from the tubular frame; and at least one tissue anchor to connect the tubular frame to native tissue.

Example

In another preferred embodiment of a transcatheter valve, there is provided a feature wherein the sleeve is shaped as a conic cylinder, said top end having a diameter of 30-35 mm and said bottom end having a diameter of 8-20 mm.

Example

In another preferred embodiment of a transcatheter valve, there is provided a feature wherein the cover is comprised of polyester, polyethylene terephthalate, decellularized pericardium, or a layered combination thereof.

Example

In a preferred embodiment of the invention, there is also provided a method for side delivery of implantable prosthetic valve to a desired location in the body, the method comprising the steps: (i) advancing a delivery catheter to the desired location in the body and delivering an expandable prosthetic valve to the desired location in the body by releasing the valve from the delivery catheter, wherein the valve comprises a tubular frame having a flow control component mounted within the tubular frame and configured to permit blood flow in a first direction through an inflow end of the valve and block blood flow in a second direction, opposite the first direction, through an outflow end of the valve, wherein the valve is compressible to a compressed configuration for introduction into the body using a delivery catheter for implanting at a desired location in the body, said compressed configuration having a long-axis oriented at an intersecting angle of between 45-135 degrees to the first direction, and expandable to an expanded configuration having a long-axis oriented at an intersecting angle of between 45-135 degrees to the first direction, wherein the long-axis of the compressed configuration of the valve is substantially parallel to a length-wise cylindrical axis of the delivery catheter, wherein the valve has a height of about 5-60 mm and a diameter of about 25-80 mm.

Example

In a preferred embodiment of the invention, there is also provided a method for loading an implantable prosthetic valve into a delivery catheter, the method comprising the steps: loading an implantable prosthetic valve sideways into a tapering fixture or funnel attached to a delivery catheter, wherein the valve comprises a tubular frame having a flow control component mounted within the tubular frame and configured to permit blood flow in a first direction through an inflow end of the valve and block blood flow in a second direction, opposite the first direction, through an outflow end of the valve, wherein the valve is compressible to a compressed configuration for introduction into the body using a delivery catheter for implanting at a desired location in the body, said compressed configuration having a long-axis oriented at an intersecting angle of between 45-135 degrees to the first direction, and expandable to an expanded configuration having a long-axis oriented at an intersecting angle of between 45-135 degrees to the first direction, wherein the long-axis of the compressed configuration of the valve is substantially parallel to a length-wise cylindrical axis of the delivery catheter, wherein the valve has a height of about 5-60 mm and a diameter of about 25-80 mm.

Example

In a preferred embodiment of the invention, there is also provided a method for loading an implantable prosthetic valve into a delivery catheter, the method comprising the steps: (i) loading an implantable prosthetic valve into a tapering fixture or funnel attached to a delivery catheter, wherein the valve comprises a tubular frame having a flow control component mounted within the tubular frame and configured to permit blood flow in a first direction through an inflow end of the valve and block blood flow in a second direction, opposite the first direction, through an outflow end of the valve, wherein said loading is perpendicular or substantially orthogonal to the first direction, wherein the valve is compressible to a compressed configuration for introduction into the body using a delivery catheter for implanting at a desired location in the body, said compressed configuration having a long-axis oriented at an intersecting angle of between 45-135 degrees to the first direction, and expandable to an expanded configuration having a long-axis oriented at an intersecting angle of between 45-135 degrees to the first direction, wherein the long-axis of the compressed configuration of the valve is substantially parallel to a length-wise cylindrical axis of the delivery catheter, wherein the valve has a height of about 5-60 mm and a diameter of about 25-80 mm.

Example

The transcatheter prosthetic heart valve may be percutaneously delivered using a transcatheter process via the femoral through the IVC, carotid, sub-xyphoid, intercostal access across the chest wall, and trans-septal to the mitral annulus through the fossa ovalis. The device is delivered via catheter to the right or left atrium and is expanded from a compressed shape that fits with the internal diameter of the catheter lumen. The compressed valve is loaded external to the patient into the delivery catheter, and is then pushed out of the catheter when the capsule arrives to the atrium. The cardiac treatment technician visualizes this delivery using available imaging techniques such as fluoroscopy or ultrasound, and in a preferred embodiment the valve self-expands upon release from the catheter since it is constructed in part from shape-memory material, such as Nitinol®, a nickel-titanium alloy used in biomedical implants.

In another embodiment, the valve may be constructed of materials that requires balloon-expansion after the capsule has been ejected from the catheter into the atrium.

The atrial collar/frame and the flow control component are expanded to their functional diameter, as they are deployed into the native annulus, providing a radial tensioning force to secure the valve. Once the frame is deployed about the tricuspid annulus, fasteners secure the device about the native annulus. Additional fastening of the device to native structures may be performed, and the deployment is complete. Further adjustments using hemodynamic imaging techniques are contemplated as within the scope of the invention in order to ensure the device is secure, is located and oriented as planned, and is functioning as a substitute or successor to the native tricuspid valve.

Drawings

Referring now to the drawings, FIG. 1 is an illustration of a plan view of a heart valve prosthesis 100 according to the present invention with a valve frame 102 having upper tension arm 128 and lower tension arm 126 mounted on and anchoring to the annulus. FIG. 1 shows lower tension arm/tab 126 extending into the Right Ventricular Outflow Tract (RVOT). The lateral, or side-delivered, delivery of the valve 100 through the inferior vena cava, provides for direct access to the valve annulus without the need to delivery a compressed valve around a right angle turn, as is required for IVC delivery of axially, or vertically loaded, traditional transcatheter valves. FIG. 1 shows one embodiment where a screw or other anchor device 138 is used in conjunction with the tension-mounting method described herein where upper and lower tension arms on the anterior leaflet side anchor the valve in place, and a secondary anchor element completes the securement of the valve in the annular site.

FIG. 1 shows polyester mesh covering 108 a valve tubular frame 102 encircling a collapsible flow control sleeve 110. FIG. 1 also shows the frame 102 having Nitinol wire frame in diamond shapes with a biocompatible covering. In one embodiment, the frame may have a pericardial material on top and a polyester material, e.g. surgical Dacron®, underneath to be in contact with the native annulus and promote ingrowth.

FIG. 2 is an illustration of a plan view of another embodiment of a heart valve prosthesis according to the present invention with a valve frame 102 having a distal upper tension arm 128 and lower tension arm 126 mounted on, and anchored to, the anterior leaflet side of the native annulus, and having a mechanical anchor element, e.g. proximal sealing cuff, 130 for anchoring on the posterior and septal side of the native annulus. The sealing cuff 130 may be a short tab on the posterior side of the valve or may be a semi-circular or circular collar or cuff that engages the atrial floor to seal the annulus from perivalvular leaks.

FIG. 3 is an illustration of a plan view of another embodiment of a heart valve prosthesis according to the present invention with a valve frame having a distal upper and lower tension arm mounted on, and anchored to, the anterior leaflet side of the native annulus, and having a mechanical anchor element, e.g. hourglass annular seal, 132 for anchoring on the posterior and/or septal side of the native annulus. The hourglass, or concave, sealing cuff 132 may be only a short segment on the posterior side of the valve or may be a semi-circular or circular combined upper and lower collar or cuff that engages the atrial floor and the ventricular ceiling to seal the annulus from perivalvular leaks. This embodiment may also include embodiments having a partial collar. This embodiment may be used in conjunction with other anchoring elements described herein.

FIG. 4 is an illustration of a PLAN view of a low-profile, e.g. 10 mm in height, wire loop embodiment of the heart valve prosthesis having an annulus support loop 140 and an upper and lower tension arm 142, 144 formed as a unitary or integral part, and covered with a biocompatible material. This embodiment shows how a low profile, side-delivered valve can having a very large diameter, 40-80 mm, with requiring an excessively large delivery catheter, as would be required by a large diameter valve that is delivered using the traditional, vertical or axial, orientation.

FIG. 5 is an illustration of a TOP view of a low-profile, e.g. 10 mm in height, wire loop embodiment of the heart valve prosthesis having an annulus support loop 140, an upper and lower tension arm 142, 144 formed as a unitary or integral part, an inner two-panel conical valve sleeve 110, and covered with a biocompatible material. FIG. 5 shows the inner two-panel sleeve and the reciprocating collapsible aperture at the lower end for delivering blood to the ventricle.

FIG. 6 is an illustration of a BOTTOM view of a low-profile, e.g. 10 mm in height, wire loop embodiment of the heart valve prosthesis having an annulus support loop, an upper and lower tension arm formed as a unitary or integral part, an inner two-panel conical valve sleeve, and covered with a biocompatible material. FIG. 6 shows a PLAN view of the inner two-panel sleeve 110 and the collapsible terminal aperture 156 at the ventricular side.

FIG. 7 is an illustration of a compressed and elongated wire loop embodiment of the heart valve prosthesis disposed within a delivery catheter 118 and having an ring shaped tubular frame 102 with braid/laser-cut 104 and an upper and lower tension arm 142, 144 formed as a unitary or integral part. FIG. 7 illustrates how a large diameter valve, using side-loading, can be delivered.

FIG. 8 is an illustration of a compressed and elongated wire loop embodiment of the heart valve prosthesis partially ejected, and partially disposed within, a delivery catheter and having an annulus support loop and an upper and lower tension arm formed as a unitary or integral part. FIG. 8 shows how a valve can be partially delivered for positioning in the annulus. The lower tension arm 144 can be used to navigate through the tricupid leaflets and chordae tendinae while the valve body, the tubular frame, 102 is still within the steerable IVC delivery catheter 118.

FIG. 9 is an illustration of a plan view of a heart valve prosthesis partially mounted within the valve annulus. By using the side-delivered valve of the present invention, the distal side of the prosthesis 142, 144 can be mounted against the anterior aspect of the native annulus, and valve function can be assessed. By allowing two pathways for blood flow, the first through the native valve near the posterior leaflet, and the second through the central aperture of the prosthetic valve, a practitioner can determine if the heart is decompensating or if valve function is less than optimal.

FIG. 10 is an illustration of a plan view of a heart valve prosthesis completely seated within the valve annulus. FIG. 19 shows that the valve can be secured in place once the valve function assessment shows that the deployment is successful. Importantly, since the valve is a low-profile valve, and fits easily within a standard, e.g. 8-12 mm, delivery catheter without requiring the forceful loading of typical transcatheter valves, the side-loading valve can be easily retrieved using the same delivery catheter that is used to deploy the valve.

FIG. 11 is an illustration of a plan view of a native right atrium of a human heart, and shows the superior vena cava (SVC), the inferior vena cava (IVC), the right atrium (RA), the tricuspid valve and annulus (TCV), the anterior leaflet (A), the posterior leaflet (P), the septal leaflet (S), the right ventricle (RV), and the right ventricular outflow tract (RVOT).

FIG. 12 is an illustration of a heart valve prosthesis according to the present invention being delivered to tricuspid valve annulus. FIG. 12 shows wire-frame lower tension arm 144 ejected from the delivery catheter 118 and being directed through the annulus and towards the right ventricular outflow tract. FIG. 12 shows an embodiment of an accordion-compressed low-profile valve 122 and shows the lower tension arm directed towards the anterior leaflet for placement into the RVOT.

FIG. 13 is an illustration of a heart valve prosthesis according to the present invention being delivered to tricuspid valve annulus. FIG. 13 shows wire-frame lower tension arm 144 and upper tension arm 142 ejected from the delivery catheter 118, the lower tension arm directed through the annulus and into the right ventricular outflow tract, and the upper tension arm staying in a supra-annular position, and causing a passive, structural anchoring of the distal side of the valve about the annulus. FIG. 13 also shows steerable anchoring catheter 150 attached to a proximal anchoring tab 152. While the valve is held in a pre-seating position, the valve can be assessed, and once valve function and patient conditions are correct, the steerable anchoring catheter can push the proximal side of the valve from its oblique angle, down into the annulus. The steerable anchoring catheter can then install one or more anchoring elements 152.

FIG. 14 is an illustration of a heart valve prosthesis according to the present invention being delivered to tricuspid valve annulus. FIG. 14 shows the entire valve ejected from the delivery catheter, the wire-frame lower tension arm directed through the annulus and into the right ventricular outflow tract, and the upper wire-frame tension arm staying in a supra-annular position, and causing a passive, structural anchoring of the distal side of the valve about the annulus, and at least one tissue anchor anchoring the proximal side of the prosthesis into the annulus tissue.

FIG. 15 is an illustration of a heart valve prosthesis according to the present invention being delivered to tricuspid valve annulus. FIG. 15 shows braided/laser cut-frame lower tension arm 126 ejected from the delivery catheter 118 and being directed through the annulus and towards the right ventricular outflow tract.

FIG. 16 is an illustration of a heart valve prosthesis according to the present invention being delivered to tricuspid valve annulus. FIG. 16 shows braided/laser cut-frame lower tension arm 126 and upper tension arm 128 ejected from the delivery catheter 118, the lower tension arm directed through the annulus and into the right ventricular outflow tract, and the upper tension arm staying in a supra-annular position, and causing a passive, structural anchoring of the distal side of the valve about the annulus.

FIG. 17 is an illustration of a heart valve prosthesis according to the present invention being delivered to tricuspid valve annulus. FIG. 17 shows the entire braided/laser cut-frame valve 102 ejected from the delivery catheter 118, the lower tension arm directed through the annulus and into the right ventricular outflow tract, and the upper tension arm staying in a supra-annular position, and causing a passive, structural anchoring of the distal side of the valve about the annulus, and at least one tissue anchor anchoring the proximal side of the prosthesis into the annulus tissue.

FIG. 18 is an illustration of a heart valve prosthesis according to the present invention being delivered to tricuspid valve annulus and shows step 1 in a valve assessment process. FIG. 18 shows braided/laser cut-frame lower tension arm ejected from the delivery catheter and being directed through the annulus and towards the right ventricular outflow tract.

FIG. 19 is an illustration of a heart valve prosthesis according to the present invention being delivered to tricuspid valve annulus, and shows Step 2 in a valve assessment process. FIG. 19 shows braided/laser cut-frame lower tension arm and upper tension arm ejected from the delivery catheter, the lower tension arm directed through the annulus and into the right ventricular outflow tract, and the upper tension arm staying in a supra-annular position, and causing a passive, structural anchoring of the distal side of the valve about the annulus. FIG. 28 shows that a steerable anchoring catheter can hold the valve at an oblique angle in a pre-attachment position, so that the valve can be assessed, and once valve function and patient conditions are correct, the steerable anchoring catheter can push the proximal side of the valve from its oblique angle, down into the annulus. The steerable anchoring catheter can then install one or more anchoring elements.

FIG. 20 is an illustration of a heart valve prosthesis according to the present invention that has been delivered to tricuspid valve annulus, and shows Step 3 in a valve assessment process. FIG. 20 shows the entire braided/laser cut-frame valve ejected from the delivery catheter, the lower tension arm directed through the annulus and into the right ventricular outflow tract, and the upper tension arm staying in a supra-annular position, and causing a passive, structural anchoring of the distal side of the valve about the annulus, and at least one tissue anchor anchoring the proximal side of the prosthesis into the annulus tissue.

FIG. 21 is an illustration of a heart valve prosthesis according to the present invention in a compressed, intra-catheter phase. The lower and upper tension arms 144, 142 are elongated to the right, and the prosthetic valve 102 is shown laterally compressed in the delivery catheter 118. The lateral compression is a function of the use of minimal structural materials, e.g. a minimal inner valve sleeve 110, and the relatively short height of the outer cylindrical frame 102. This lateral delivery provides for very large, e.g. up to 80 mm or more, valve prosthesis' to be delivered. The lateral delivery also avoids the need to perform a 90 degree right turn when delivering a valve using the IVC femoral route. This sharp delivery angle has also limited the size and make up of prior valve prosthesis', but is not a problem for the inventive valve herein.

FIG. 22 is an illustration of a profile, or plan, view of a wire-frame embodiment of the heart valve prosthesis according to the present invention in a un-compressed, post-catheter-ejection phase. FIG. 22 shows an embodiment where the upper wire-frame tension arm 142 is attached to the tubular frame 102, but the lower tension arm 144 is shaped in an S-shape and connects only to the upper tension arm 142.

FIG. 23 is an illustration of a profile, or plan, view of a braid or laser-cut frame embodiment of the heart valve prosthesis according to the present invention in a un-compressed, post-catheter-ejection phase. FIG. 23 shows an embodiment where the upper braid or laser-cut tension arm 128 is attached to the upper edge of the tubular frame 102, and the lower tension arm 126 is attached to the lower edge of the tubular frame 102.

FIG. 24 is an illustration of a TOP view of a heart valve prosthesis according to the present invention having covered wire loop for the upper tension arm(s). FIG. 24 shows the tubular frame 102 having an inner sleeve 110 sewn into the central aperture 106, with the two (2) panels extending downward (into the page) in a ventricular direction. FIG. 24 shows the upper tension arms 142 oriented towards the anterior leaflet side of the atrial floor, shown in dashed outline.

FIG. 25 is an illustration of a PLAN view of a heart valve prosthesis according to the present invention having a wire loop construction for the upper 142 and lower 144 tension arms.

FIG. 26 is an illustration of a CUT-AWAY PLAN view of a heart valve prosthesis according to the present invention, and shows the inner panel valve sleeve 110 mounted within the inner space defined by the tubular frame.

FIG. 27 is an illustration of a BOTTOM view of a heart valve prosthesis according to the present invention having a covered wire loop for the lower tension arm 144. FIG. 27 shows the tubular frame 102 having an inner sleeve 110 sewn into the central aperture, with the two (2) panels extending upward (out of the page) in a ventricular direction. FIG. 27 shows the lower tension arm 144 oriented towards the anterior leaflet side of the ventricular ceiling, shown in dashed outline.

FIG. 28 is an illustration of a TOP view of a heart valve prosthesis according to the present invention having covered braid or laser-cut frame 102 for the upper tension arm 128. FIG. 28 shows the tubular frame 102 having an inner sleeve 110 sewn into the central aperture, with the two (2) panels extending downward (into the page) in a ventricular direction. FIG. 28 shows the upper tension arm 128 oriented towards the anterior leaflet side of the atrial floor, shown in dashed outline.

FIG. 29 is an illustration of a PLAN view of a heart valve prosthesis according to the present invention having a braid or laser-cut frame construction 102 for the upper and lower tension arms 128, 126.

FIG. 30 is an illustration of a CUT-AWAY PLAN view of a heart valve prosthesis according to the present invention, and shows the inner panel valve sleeve 110 mounted within the inner space defined by the tubular frame 102.

FIG. 31 is an illustration of a BOTTOM view of a heart valve prosthesis according to the present invention having a covered braid or laser-cut frame for the lower tension arm. FIG. 31 shows the tubular frame 102 having an inner sleeve 110 sewn into the central aperture, with the two (2) panels extending upward (out of the page) in a ventricular direction. FIG. 31 shows the lower tension arm 126 oriented towards the anterior leaflet side of the ventricular ceiling, shown in dashed outline.

FIG. 32 is an illustration of a heart valve prosthesis according to the present invention having a wire loop construction for the tubular frame 102, with two vertical support posts 154 extending down the edge on opposing sides of the sleeve 110. During compression into the delivery catheter 118 (not shown), the posts 154 are engineered to fold horizontally during compression, and to elastically unfold during ejection to deploy the valve sleeve 110.

FIG. 33 is an illustration of a CUT-AWAY PLAN view of a heart valve prosthesis according to the present invention, and shows a two-post embodiment 154 of the inner panel valve sleeve 110 mounted within the inner space defined by the tubular frame 102.

FIG. 34 is an illustration of a CUT-AWAY PLAN view of a heart valve prosthesis according to the present invention, and shows a three-panel, three-post embodiment of the inner panel valve sleeve mounted within the inner space defined by the tubular frame.

FIG. 35 is an illustration of a low-profile, side-delivered heart valve prosthesis according to the present invention having a braid or laser-cut construction for the tubular frame 102, with a valve sleeve 110 that extends beyond the bottom of the tubular frame. FIG. 35 shows a longer lower tension arm 126 for extending sub-annularly towards the RVOT, and a shorter upper tension arm 128 for extending over the atrial floor. FIG. 35 shows an elongated two (2) panel valve sleeve 110 that extends into the sub-annular leaflet space. The tubular frame 102 shown in FIG. 35 is about 10 mm in height and the valve sleeve 110 extends about 10 mm below the bottom of the tubular frame, resulting in a valve 20 mm in total height.

FIG. 36 is an illustration of a low-profile, side-delivered heart valve prosthesis having a braid or laser-cut tubular frame and extended valve sleeve compressed within a delivery catheter 118. FIG. 36 shows the valve attached to a secondary steerable catheter 150 for ejecting, positioning, and anchoring the valve. The secondary catheter 150 can also be used to retrieve a failed deployment of a valve.

FIG. 37 is an illustration of a heart valve prosthesis having a braid or laser-cut tubular frame and extended valve sleeve shown partially compressed within a delivery catheter, and partially ejected from the delivery catheter. FIG. 37 shows that while the valve is still compressed the lower tension arm can be manipulated through the leaflets and chordae tendinae to find a stable anterior-side lodgment for the distal side of the valve.

FIG. 38 is an illustration of a heart valve prosthesis having a braid or laser-cut tubular frame and extended valve sleeve engaging the tissue on the anterior side of the native annulus with the curved distal side-wall of the tubular frame sealing around the native annulus. FIG. 38 shows the valve held by the steerable secondary catheter at an oblique angle while valve function is assessed.

FIG. 39 is an illustration of a heart valve prosthesis having a braid or laser-cut tubular frame and extended valve sleeve fully deployed into the tricuspid annulus. The distal side of the valve is shown engaging the tissue on the anterior side of the native annulus with the curved distal side-wall of the tubular frame sealing around the native annulus, and with the proximal side-wall tension-mounted into the posterior side of the native annulus.

FIG. 40 is an illustration of a TOP view of a heart valve prosthesis according to the present invention having braid or laser-cut wire frame 102 and shown mounted within a cross-sectional view of the atrial floor at the annulus.

FIG. 41 is an illustration of a BOTTOM view of a heart valve prosthesis according to the present invention having braid or laser-cut wire frame 102 for a lower tension arm 126 and shown mounted within a cross-sectional view of the ventricular ceiling at the annulus. FIG. 41 shows the two panel valve sleeve 110 in an open position 106, e.g. atrial systole and ventricular diastole. FIG. 41 shows RVOT as a darkened circle.

FIG. 42 is an illustration of a PLAN view of an embodiment of the prosthetic valve shown in a compressed configuration within a delivery catheter. FIG. 42 shows the tubular frame wall rolled-over, outwardly, resulting in a 50% reduction in height of the catheter-housed valve. The low profile, side-delivered valves of the present invention do not require the aggressive, strut-breaking, tissue-tearing, stitch-pulling forces that traditional transcatheter valves are engineered to mitigate.

FIG. 43 is an illustration of a cross-sectional view of one embodiment of a compressed valve within a delivery catheter 118. This cross-sectional end view shows one embodiment of a single-fold compression configuration where the tubular frame wall 102 and attached two-panel sleeve 110 are rolled-over, outwardly, resulting in a 50% reduction in height, and providing the ability to fit within the inner diameter of a 1 cm (10 mm) delivery catheter.

FIG. 44 is an illustration of a cross-sectional view of another embodiment of a compressed valve within a delivery catheter. This cross-sectional end view shows another embodiment of a single-fold compression configuration where the tubular frame wall and attached two-panel sleeve are folded-over, outwardly, resulting in a 50% reduction in height, and providing the ability to fit within the inner diameter of a 1 cm (10 mm) delivery catheter.

FIG. 45 is an illustration of a cross-sectional view of an embodiment of the prosthetic valve to further illustrate how the folding and rolling configurations can be effectuated due to the minimal material requirement of the low-profile, side-delivered valve 102, 110.

FIG. 46 (a)-(b)-(c) is an illustration of a sequence of a low-profile valve being rolled into a configuration for placement within a delivery catheter. Tubular frame 102 having aperture 106 supports sleeve 110.

FIG. 47 is an illustration of an END-VIEW of a low-profile valve that has been longitudinally rolled and loaded within a delivery catheter 118, and show frame 102 and sleeve 110.

FIG. 48 is an illustration of a rotational lock embodiment of the present invention where the prosthetic valve is delivered to the native annulus with an off-set sub-annular tension arm/tab 126 positioned below the native annulus, and an off-set supra-annular tension arm/tab 128 positioned above the native annulus, while the tubular frame 102 is partially rolled off-set from the annular plane along a longitudinal axis.

FIG. 49 is an illustration of a rotational lock embodiment of the present invention where the prosthetic valve is delivered to the native annulus with an off-set sub-annular tension arm/tab 126 positioned below the native annulus, and an off-set supra-annular tension arm/tab 128 positioned above the native annulus, while the tubular frame 102 is rolled into functional position parallel to the annular plane. Once the valve is rolled into position, and the tension arms are locked against the sub-annular and supra-annular tissues, the valve can also be further anchored using traditional anchoring elements as disclosed herein.

FIG. 50 is an illustration of a low-profile, e.g. 8-20 mm, side-delivered prosthetic valve 100 shown deployed into the native annulus. FIG. 50 shows that low-profile, side-delivered valves can be delivered and traditionally anchored with or without the need for shaped, tension arms.

FIG. 51 is an illustration of a low-profile, e.g. 8-20 mm, side-delivered prosthetic valve having frame 102 and sleeve 110 shown compressed or housed within the delivery catheter 118.

FIG. 52 is an illustration of a low-profile, e.g. 8-20 mm, side-delivered prosthetic valve shown ejected from the delivery catheter 118 and positioned against the anterior side of the native annulus. While the valve is held at this oblique angle by secondary catheter 150, valve function and patient condition are assessed, and if appropriate the valve is completely deployed within the native annulus, and anchored using traditional anchoring elements.

FIG. 53 is an illustration of an open cross-section view of a low-profile, side-delivered prosthetic valve and shows the inner valve sleeve 110 and frame 102.

FIG. 54 is an illustration of a two-panel embodiment of an inner valve sleeve 110.

FIG. 55 is an illustration of one embodiment of an inner valve sleeve 110 having two rigid support posts 154.

FIG. 56 is an illustration of a three-panel embodiment of an inner valve sleeve 110.

FIG. 57 is an illustration of a three-panel embodiment of an inner valve sleeve 110 having three rigid support posts 154.

FIG. 58 is a flowchart describing one set of method steps for delivery of a low-profile, side-delivered prosthetic valve.

STEP 1: Provide low profile, side-loading prosthetic valve;

STEP 2: compress valve into a delivery catheter, where the valve is compressed along a horizontal axis that is parallel to the length-wise axis of the delivery catheter;

STEP 3: advance the delivery catheter containing the side-loaded valve to the right atrium via the inferior vena cava;

STEP 4: expel the side-loaded valve from the delivery catheter, and using a steerable secondary catheter, seat the valve into the native annulus;

STEP 5: optionally, before fully seating the valve into the native annulus, hold the valve at an oblique angle to assess valve function, and then after assessing valve function, fully seat the valve into the native annulus.

FIG. 59 is an illustration of a plan view of a tissue anchor having a floating radio-opaque marker. This figure shows the tissue anchor accessing the annular tissue with the radio-opaque marker at the distal end of the anchor and in contact with the atrial surface of the annular tissue. This figure shows the tissue anchor advancing into the annular tissue with the radio-opaque marker threaded onto the tissue anchor and maintaining position on the atrial surface of the annular tissue. This figure shows the tissue anchor completely advanced into the annular tissue such that the tissue anchor and the threaded floating marker are now adjacent, indicating the desired depth, tension, and/or plication of the tissue anchor with respect to the annular tissue.

FIG. 60 is an illustration of a plan view of of a tissue anchor having a straight thread and a constant pitch.

FIG. 61 is an illustration of a plan view of of a tissue anchor having a straight thread and a variable pitch.

FIG. 62 is an illustration of a plan view of of a tissue anchor having a tapered thread and a constant pitch.

FIG. 63 is an illustration of a plan view of of a tissue anchor having a sunken taper thread and a variable pitch.

FIG. 64 is an illustration of Step 1 of a 4 step process for clipping a low profile valve to annular tissue, as shown here in a non-limiting example of clipping to a proximal or anterior side of the native annulus. FIG. 64 shows a low profile valve being inserted into the valve annulus and low profile valve having an integral anchor delivery conduit or channel with an anchor disposed in the lumen of the channel and an anchor delivery catheter attached to the anchor.

FIG. 65 is an illustration of Step 2 of a 4 step process for clipping a low profile valve to annular tissue, as shown here in a non-limiting example of clipping to a proximal or anterior side of the native annulus. FIG. 65 shows a low profile valve completely deployed within the valve annulus and an integral anchor delivery conduit or channel with an anchor disposed in the lumen of the channel and an anchor delivery catheter attached to the anchor.

FIG. 66 is an illustration of Step 3 of a 4 step process for clipping a low profile valve to annular tissue, as shown here in a non-limiting example of clipping to a proximal or anterior side of the native annulus. FIG. 66 shows the anchor being pushed out of the lumen of the delivery conduit or channel and into the annular tissue.

FIG. 67 is an illustration of Step 4 of a 4 step process for clipping a low profile valve to annular tissue, as shown here in a non-limiting example of clipping to a proximal or anterior side of the native annulus. FIG. 67 shows the anchor in a locked position after being pushed out of the lumen of the delivery conduit or channel and into the annular tissue, thus anchoring the proximal side of the low profile valve.

FIG. 68 is an illustration of Step 1 of a 5 step process for clipping a low profile valve to annular tissue, as shown here in a non-limiting example of clipping to a proximal or anterior side of the native annulus. FIG. 68 shows catheter delivery of an attachment wire with the clip housed within the lumen of the clip delivery catheter.

FIG. 69 is an illustration of Step 2 of a 5 step process for clipping a low profile valve to annular tissue, as shown here in a non-limiting example of clipping to a proximal or anterior side of the native annulus. FIG. 69 shows the clip delivery catheter inserted into an intra-annular space and shows an attachment wire and shows the clip housed within the lumen of the clip delivery catheter.

FIG. 70 is an illustration of Step 3 of a 5 step process for clipping a low profile valve to annular tissue, as shown here in a non-limiting example of clipping to a proximal or anterior side of the native annulus. FIG. 70 shows a receiver element ejected from the delivery catheter and positioned behind tissue to be captured.

FIG. 71 is an illustration of Step 4 of a 5 step process for clipping a low profile valve to annular tissue, as shown here in a non-limiting example of clipping to a proximal or anterior side of the native annulus. FIG. 71 shows an anchor element piercing the annular tissue and inserting into a receiver element.

FIG. 72 is an illustration of Step 5 of a 5 step process for clipping a low profile valve to annular tissue, as shown here in a non-limiting example of clipping to a proximal or anterior side of the native annulus. FIG. 72 shows that the clip delivery catheter is withdrawn and the anchor element and receiver element are connected to the annular tissue and a also connected by connector wire to the low profile valve.

FIG. 73 is an illustration of one embodiment of a partial cut-away interior view of a tri-leaflet embodiment of a low-profile, e.g. 8-20 mm, side-delivered prosthetic valve.

FIG. 74 is an illustration of another embodiment of a partial cut-away interior view of a tri-leaflet embodiment of a low-profile, e.g. 8-20 mm, side-delivered prosthetic valve.

FIG. 75 is an illustration of a top view of a tri-leaflet embodiment of a low-profile, e.g. 8-20 mm, side-delivered prosthetic valve.

FIG. 76 is an illustration of the trans-septal (femoral-IVC) delivery of a low-profile, e.g. 8-20 mm, side-delivered prosthetic MITRAL valve shown partially housed within the delivery catheter, and partially ejected for deployment into the native mitral annulus.

FIG. 77 is an illustration of a low-profile, e.g. 8-20 mm, side-delivered prosthetic MITRAL valve shown housed within the delivery catheter.

FIG. 78 is an illustration of a low-profile, e.g. 8-20 mm, side-delivered prosthetic MITRAL valve shown partially housed within a delivery catheter and partially laterally ejected from the delivery catheter and positioned for deployment against the anterior side of the native mitral annulus.

FIG. 79 is an illustration of a low-profile, e.g. 8-20 mm, side-delivered prosthetic MITRAL valve shown ejected from the delivery catheter and positioned against the anterior side of the native mitral annulus.

FIG. 80 is an illustration of a side or plan view of a low-profile, e.g. 8-20 mm, side-delivered prosthetic valve shown deployed into the native MITRAL annulus.

PARTS LIST

  • 100 side-loading transcatheter heart valve replacement
  • 102 a ring-shaped tubular frame
  • 104 a braid, wire, or laser-cut wire frame
  • 106 substantially circular central aperture,
  • 108 biocompatible material cover for frame;
  • 110 valve sleeve, aka a collapsible flow control sleeve
  • 112,114 valve sleeve panels
  • 116 a reciprocating closable channel from a heart atrium to a heart ventricle;
  • 118 a transcatheter implantation (delivery) catheter
  • 120 an internal diameter from 22 Fr (7.33 mm) to 34 Fr (11.33 mm),
  • 122 compressed tubular frame oriented parallel to length-wise axis delivery catheter
  • 124 length-wise axis of a delivery catheter.
  • 126 lower tension arm/tab, braid/laser
  • 128 upper tension arm/tab, braid/laser
  • 130 proximal sealing cuff
  • 132 hourglass annular seal
  • 134 upper proximal tab
  • 136 lower proximal tab
  • 138 screw anchor
  • 140 wire tubular frame
  • 142 upper tension arm/tab, wire
  • 144 lower tension arm/tab, wire
  • 146 substantially circular central aperture
  • 148 upper proximal tab, wire
  • 150 steerable anchoring/deployment catheter
  • 152 screw/anchor tab
  • 154 valve sleeve support posts
  • 156 sleeve terminus aperture

Various of the above-disclosed and other features and functions, or alternatives thereof, may be combined into many other different systems or applications. Various presently unforeseen or unanticipated alternatives, modifications, variations or improvements therein may be subsequently made by those skilled in the art, each of which is also intended to be encompassed by the disclosed embodiments.

Having described embodiments for the invention herein, it is noted that modifications and variations can be made by persons skilled in the art in light of the above teachings. It is therefore to be understood that changes may be made in the particular embodiments of the invention disclosed which are within the scope and spirit of the invention as defined by the appended claims. Having thus described the invention with the details and particularity required by the patent laws, what is claimed and desired protected by Letters Patent is set forth in the appended claims.

Claims

1. A side-delivered transcatheter prosthetic valve comprising:

a compressible tubular frame having a side wall and a central axial lumen, said tubular frame having a height of 8-20 mm and a diameter of 40-80 mm,
an atrial sealing cuff attached to a top edge of the side wall,
a subannular anchoring component attached to the tubular frame, said subannular anchoring component selected from one or more of the group consisting of a lower tension arm extending from a distal side of the tubular frame, a proximal anchoring tab extending from a proximal side of the tubular frame, a ventricular sealing collar attached to a bottom edge of the side wall, and at least one tissue anchor to connect the tubular frame to native tissue, and
a flow control component comprising a leaflet structure having three leaflets of pericardial material sewn to a leaflet frame to form a rounded cylinder mounted within the lumen of the tubular frame and configured to permit blood flow in a first direction through an inflow end of the valve and block blood flow in a second direction, opposite the first direction, through an outflow end of the valve,
wherein the valve is compressible to a compressed configuration for introduction into the body using a delivery catheter for implanting at a mitral valve annulus or tricuspid valve annulus of a patient, said delivery catheter having an internal diameter from 22 Fr (7.33 mm) to 34 Fr (11.33 mm),
said compressed configuration having a long-axis that is substantially parallel to a length-wise cylindrical axis of the delivery catheter, and substantially orthogonal to the blood flow through the flow control component mounted in the central axial lumen,
said compressed configuration having a height and a width to fit within the delivery catheter, the height and width of the compressed configuration compressed by longitudinal/length-wise rolling or folding,
wherein the valve is expandable to an expanded configuration having a long-axis substantially orthogonal to the blood flow through the flow control component mounted in the central axial lumen,
said tubular frame and said atrial sealing cuff having a polyester cover, and said tubular frame and said atrial sealing cuff made from superelastic shape-memory material selected from Ni—Ti alloy, Cu—Zn—Al—Ni alloys, Cu—Al—Ni alloys, a polymer composite, a composite containing one or more of carbon nanotubes, carbon fibers, metal fibers, glass fibers, and polymer fibers, a stainless steel, a cobalt chromium material, and a titanium material.

2. The valve of claim 1, wherein the at least one tissue anchor to connect the tubular frame to native tissue is an anterior leaflet clip or anchor, a posterior leaflet clip or anchor, or a septal leaflet clip or anchor.

3. The valve of claim 1, wherein said tubular frame is comprised of a braided, wire, or laser-cut wire frame, and said tubular frame is covered with a biocompatible material.

4. The valve of claim 1, wherein the tubular frame has a side profile of a flat cone shape having a diameter R of 40-80 mm, a diameter r of 20-60 mm, and a height of 8-20 mm.

5. The valve of claim 1, wherein the tubular frame has an inner surface and an outer surface, said inner surface and said outer surface covered with pericardial tissue.

6. The valve of claim 1, wherein the tubular frame has a side profile of an hourglass shape having a top diameter R1 of 40-80 mm, a bottom diameter R2 of 50-70 mm, an internal diameter r of 20-60 mm, and a height of 8-20 mm.

7. The valve of claim 1, wherein the flow control component has an internal diameter of 20-60 mm and a height of 8-20 mm.

8. The valve of claim 1, wherein the flow control component is supported with one or more longitudinal supports integrated into or mounted upon the flow control component, the one or more longitudinal supports selected from rigid or semi-rigid posts, rigid or semi-rigid ribs, rigid or semi-rigid battons, rigid or semi-rigid panels, and combinations thereof.

9. The valve of claim 1, wherein the lower tension arm extending from the distal side of the tubular frame is comprised of wire loop or wire frame, integrated frame section, or stent, and extends from about 10-40 mm away from the tubular frame.

10. The valve of claim 1, comprising (i) an upper tension arm attached to a distal upper edge of the tubular frame, the upper tension arm comprised of wire loop or wire frame extending from about 2-20 mm away from the tubular frame, and (ii) the lower tension arm extending from the distal side of the tubular frame is comprised of wire loop or wire frame, integrated frame section, or stent, and extends from about 10-40 mm away from the tubular frame.

11. A method for side delivery of implantable prosthetic valve between a ventricle and an atrium of a heart, the method comprising the steps:

advancing a delivery catheter containing the valve of claim 1 in a compressed configuration to the atrium of the heart,
and
partially releasing the valve from the delivery catheter to position a distal side wall of the tubular frame at an oblique angle against a distal portion of the native annulus and allowing blood to flow from the atrium to the ventricle both through the native valve and through the prosthetic valve,
releasing the remainder of the prosthetic valve from the delivery catheter to an expanded configuration to assess valve function at the oblique angle before seating the valve completely into the native annulus, pushing a proximal side wall of the tubular frame into the native annulus to complete seating of the valve in the native annulus, wherein said atrial sealing cuff is disposed on the atrial floor and the tubular frame is seated within the native annulus, and anchoring the subannular anchoring component of the valve to native annular or subannular tissue,
wherein the native valve is a tricuspid valve or a mitral valve.

12. The method of claim 11, wherein releasing the valve from the delivery catheter is selected from the steps consisting of: (i) pulling the valve out of the delivery catheter using a rigid elongated pushing rod that is releasably connected to the distal side of the valve, wherein advancing the pushing rod away from the delivery catheter pulls the compressed valve out of the delivery catheter, or (ii) pushing the valve out of the delivery catheter using a rigid elongated pushing rod that is releasably connected to the proximal side of the valve, wherein advancing the pushing rod out of from the delivery catheter pushes the compressed valve out of the delivery catheter.

13. The method of claim 11, comprising the additional step of anchoring one or more secondary tissue anchors attached to the valve into native tissue.

14. The method of claim 11, wherein the subannular anchoring component is a lower tension arm extending from a distal side of the tubular frame.

15. The method of claim 11, comprising the additional step of rotating the heart valve prosthesis using a steerable catheter along an axis parallel to the plane of the valve annulus, wherein an upper tension arm mounted on the valve is conformationally pressure locked against supra-annular tissue, and wherein the lower tension arm mounted on the valve is conformationally pressure locked against sub-annular tissue.

Referenced Cited
U.S. Patent Documents
5397351 March 14, 1995 Pavcnik
6197013 March 6, 2001 Reed
6582467 June 24, 2003 Teitelbaum
7074189 July 11, 2006 Montegrande
7125418 October 24, 2006 Duran
7331991 February 19, 2008 Kheradvar
7374571 May 20, 2008 Pease
7449027 November 11, 2008 Hunt
7717952 May 18, 2010 Case
7753949 July 13, 2010 Lamphere
7828840 November 9, 2010 Biggs
7846199 December 7, 2010 Paul
8303648 November 6, 2012 Grewe
8366768 February 5, 2013 Zhang
8491650 July 23, 2013 Wiemeyer
8568474 October 29, 2013 Yeung
8641752 February 4, 2014 Holm
8696743 April 15, 2014 Holecek
8728153 May 20, 2014 Bishop
8758395 June 24, 2014 Kleshinski
8846390 September 30, 2014 Dove
8876892 November 4, 2014 Tran
8915958 December 23, 2014 Braido
8926690 January 6, 2015 Kovalsky
8926692 January 6, 2015 Dwork
8926694 January 6, 2015 Costello
8940044 January 27, 2015 Hammer
8956404 February 17, 2015 Börtlein
9011524 April 21, 2015 Eberhardt
9017399 April 28, 2015 Gross
9050188 June 9, 2015 Schweich
9072604 July 7, 2015 Melnick
9119714 September 1, 2015 Shandas
9216076 December 22, 2015 Mitra
9241792 January 26, 2016 Benichou
9248016 February 2, 2016 Oba
9259215 February 16, 2016 Chou
9277990 March 8, 2016 Klima
9289282 March 22, 2016 Olson
9289296 March 22, 2016 Braido
9295547 March 29, 2016 Costello
9301839 April 5, 2016 Stante
9456899 October 4, 2016 Yeung
9339367 May 17, 2016 Carpenter
9370418 June 21, 2016 Pintor
9381083 July 5, 2016 Costello
9387075 July 12, 2016 Börtlein
9393111 July 19, 2016 Ma
9433500 September 6, 2016 Chau
9440054 September 13, 2016 Bishop
9474604 October 25, 2016 Centola
9486306 November 8, 2016 Tegels
9510941 December 6, 2016 Bishop
9554902 January 31, 2017 Braido
9579196 February 28, 2017 Morriss
9579200 February 28, 2017 Lederman
9610159 April 4, 2017 Christianson
9615925 April 11, 2017 Subramanian
9629719 April 25, 2017 Rothstein
9636222 May 2, 2017 Oslund
9649191 May 16, 2017 Savage
9662203 May 30, 2017 Sheehan
9662209 May 30, 2017 Gross
9675454 June 13, 2017 Vidlund
9675485 June 13, 2017 Essinger
9687343 June 27, 2017 Börtlein
9707076 July 18, 2017 Stack
9713530 July 25, 2017 Cabiri
9750607 September 5, 2017 Ganesan
9763778 September 19, 2017 Börtlein
9763779 September 19, 2017 Börtlein
9839511 December 12, 2017 Ma
9849011 December 26, 2017 Zimmerman
9855384 January 2, 2018 Cohen
9861464 January 9, 2018 Azimpour
10058426 August 28, 2018 Barbarino
9895219 February 20, 2018 Costello
9901330 February 27, 2018 Akpinar
9918838 March 20, 2018 Ring
9943409 April 17, 2018 Kim
9949825 April 24, 2018 Braido
9968444 May 15, 2018 Millwee
9968445 May 15, 2018 Morriss
9980815 May 29, 2018 Nitzan
9987121 June 5, 2018 Blanzy
10010411 July 3, 2018 Peter
10010412 July 3, 2018 Taft
10022054 July 17, 2018 Najafi
10022222 July 17, 2018 Groothuis
10022223 July 17, 2018 Bruchman
10028821 July 24, 2018 Centola
10028831 July 24, 2018 Morin
10034667 July 31, 2018 Morris
10034747 July 31, 2018 Harewood
10039638 August 7, 2018 Bruchman
10058315 August 28, 2018 Rafiee
10058411 August 28, 2018 Fifer
10058421 August 28, 2018 Arai
10064405 September 4, 2018 Dale
10080653 September 25, 2018 Conklin
10085835 October 2, 2018 Thambar
10105224 October 23, 2018 Buchbinder
10117741 November 6, 2018 Schweich
10123874 November 13, 2018 Khairkhahan
10130331 November 20, 2018 Stigall
10130467 November 20, 2018 Braido
10149685 December 11, 2018 Kizuka
10154905 December 18, 2018 Duffy
10179043 January 15, 2019 Cohen-Tzemach
10182908 January 22, 2019 Tubishevitz
10182911 January 22, 2019 Hilukka
10206775 February 19, 2019 Kovalsky
10219895 March 5, 2019 Wagner
10219896 March 5, 2019 Sandstrom
10220192 March 5, 2019 Drasier
10226178 March 12, 2019 Cohen
10226335 March 12, 2019 Cartledge
10245142 April 2, 2019 Bonhoeffer
10258467 April 16, 2019 Hou
10265173 April 23, 2019 Griffin
10321987 June 18, 2019 Wang
10321995 June 18, 2019 Christianson
10327895 June 25, 2019 Lozonschi
10327899 June 25, 2019 Sandstrom
10329066 June 25, 2019 Kruetzfeldt
10350047 July 16, 2019 Rajpara
10357361 July 23, 2019 Rafi
10368989 August 6, 2019 Duffy
10398550 September 3, 2019 Chalekian
10426611 October 1, 2019 Hariton
10433957 October 8, 2019 Khouengboua
10433960 October 8, 2019 Sutherland
20030040772 February 27, 2003 Hyodoh
20030153901 August 14, 2003 Herweck
20030166990 September 4, 2003 Trauthen
20030171801 September 11, 2003 Bates
20060015167 January 19, 2006 Armstrong
20060195180 August 31, 2006 Kheradvar
20060271098 November 30, 2006 Peacock
20070027535 February 1, 2007 Purdy
20070032850 February 8, 2007 Ruiz
20070038295 February 15, 2007 Case
20070162102 July 12, 2007 Ryan
20070208417 September 6, 2007 Agnew
20070213805 September 13, 2007 Schaeffer
20070233176 October 4, 2007 Gilsen
20070233228 October 4, 2007 Eberhardt
20070288087 December 13, 2007 Fearnot
20080004686 January 3, 2008 Hunt
20080020013 January 24, 2008 Reyes
20080132999 June 5, 2008 Mericle
20080200977 August 21, 2008 Paul
20080208332 August 28, 2008 Lamphere
20080262609 October 23, 2008 Gross
20080275550 November 6, 2008 Kheradvar
20090192586 July 30, 2009 Tabor
20090254174 October 8, 2009 Case
20090264991 October 22, 2009 Paul
20090094189 April 9, 2009 Macauley
20090287290 November 19, 2009 Macaulay
20100160773 June 24, 2010 Cohen
20100161043 June 24, 2010 Maisano
20100168844 July 1, 2010 Toomes
20100174363 July 8, 2010 Castro
20100179583 July 15, 2010 Carpenter
20100179584 July 15, 2010 Carpenter
20100179647 July 15, 2010 Carpenter
20100305685 December 2, 2010 Millwee
20110029071 February 3, 2011 Zlotnick
20110098804 April 28, 2011 Yeung
20110125145 May 26, 2011 Mody
20110172764 July 14, 2011 Badhwar
20110245917 October 6, 2011 Savage
20110251675 October 13, 2011 Dwork
20110257721 October 20, 2011 Tabor
20120022633 January 26, 2012 Olson
20120022640 January 26, 2012 Gross
20120022644 January 26, 2012 Reich
20120035701 February 9, 2012 To
20120123531 May 17, 2012 Tsukashima
20120137521 June 7, 2012 Millwee
20120172981 July 5, 2012 DuMontelle
20120209375 August 16, 2012 Madrid
20120232574 September 13, 2012 Kim
20120277853 November 1, 2012 Rothstein
20130055941 March 7, 2013 Holecek
20130131714 May 23, 2013 Wang
20130131792 May 23, 2013 Miller
20130166017 June 27, 2013 Cartledge
20130184742 July 18, 2013 Ganesan
20130190857 July 25, 2013 Mitra
20130197621 August 1, 2013 Ryan
20130226289 August 29, 2013 Shaolian
20130238010 September 12, 2013 Johnson
20130253570 September 26, 2013 Bates
20130274618 October 17, 2013 Hou
20130274855 October 17, 2013 Stante
20130282110 October 24, 2013 Schweich
20130297010 November 7, 2013 Bishop
20130331929 December 12, 2013 Mitra
20140000112 January 2, 2014 Braido
20140005540 January 2, 2014 Merhi
20140005768 January 2, 2014 Thomas
20140039511 February 6, 2014 Morris
20140081383 March 20, 2014 Eberhardt
20140088680 March 27, 2014 Costello
20140107758 April 17, 2014 Glazier
20140110279 April 24, 2014 Kruetzfeldt
20140114403 April 24, 2014 Dale
20140135895 May 15, 2014 Andress
20140172070 June 19, 2014 Seguin
20140180069 June 26, 2014 Millett
20140180070 June 26, 2014 Millett
20140194704 July 10, 2014 Millett
20140214069 July 31, 2014 Franklin
20140214159 July 31, 2014 Vidlund
20140222137 August 7, 2014 Miller
20140222142 August 7, 2014 Kovalsky
20140249566 September 4, 2014 Quinn
20140276616 September 18, 2014 Smith
20140276971 September 18, 2014 Kovach
20140277388 September 18, 2014 Skemp
20140277408 September 18, 2014 Folan
20140296969 October 2, 2014 Tegels
20140303718 October 9, 2014 Tegels
20140303724 October 9, 2014 Bluestein
20140309732 October 16, 2014 Solem
20140324161 October 30, 2014 Tegels
20140350662 November 27, 2014 Vaturi
20140371789 December 18, 2014 Harton
20140379076 December 25, 2014 Vidlund
20150005808 January 1, 2015 Chouinard
20150005874 January 1, 2015 Vidlund
20150039081 February 5, 2015 Costello
20150051687 February 19, 2015 Dickerhoff
20150094802 April 2, 2015 Buchbinder
20150112188 April 23, 2015 Stigall
20150119982 April 30, 2015 Quill
20150127093 May 7, 2015 Hosmer
20150142103 May 21, 2015 Vidlund
20150196391 July 16, 2015 Dwork
20150202044 July 23, 2015 Chau
20150216661 August 6, 2015 Hacohen
20150230919 August 20, 2015 Chau
20150245934 September 3, 2015 Lombardi
20150257880 September 17, 2015 Börtlein
20150257882 September 17, 2015 Börtlein
20150272731 October 1, 2015 Racchini
20150289971 October 15, 2015 Costello
20150289975 October 15, 2015 Costello
20150297241 October 22, 2015 Yodfat
20150305867 October 29, 2015 Liu
20150313701 November 5, 2015 Krahbichler
20150342717 December 3, 2015 O'Donnell
20150351904 December 10, 2015 Cooper
20150359629 December 17, 2015 Ganesan
20160008130 January 14, 2016 Hasin
20160022417 January 28, 2016 Karapetian
20160030165 February 4, 2016 Mitra
20160030167 February 4, 2016 Delaloye
20160038283 February 11, 2016 Divekar
20160045165 February 18, 2016 Braido
20160045306 February 18, 2016 Agrawal
20160045309 February 18, 2016 Valdez
20160067031 March 10, 2016 Kassab
20160081799 March 24, 2016 Leo
20160095703 April 7, 2016 Thomas
20160095704 April 7, 2016 Whitman
20160113764 April 28, 2016 Sheahan
20160113766 April 28, 2016 Ganesan
20160113768 April 28, 2016 Ganesan
20160143721 May 26, 2016 Rosenbluth
20160143730 May 26, 2016 Kheradvar
20160143735 May 26, 2016 Subramanian
20160143739 May 26, 2016 Horgan
20160158004 June 9, 2016 Kumar
20160158007 June 9, 2016 Centola
20160158008 June 9, 2016 Miller
20160166382 June 16, 2016 Nguyen
20160184488 June 30, 2016 Toyoda
20160194425 July 7, 2016 Mitra
20160213470 July 28, 2016 Ahlberg
20160220367 August 4, 2016 Barrett
20160220372 August 4, 2016 Medema
20160220734 August 4, 2016 Dyamenahalli
20160228250 August 11, 2016 Casley
20160235530 August 18, 2016 Thomas
20160256269 September 8, 2016 Cahalane
20160256270 September 8, 2016 Folan
20160270911 September 22, 2016 Ganesan
20160303804 October 20, 2016 Grbic
20160310274 October 27, 2016 Gross
20160317301 November 3, 2016 Quadri
20160324639 November 10, 2016 Nguyen
20160331534 November 17, 2016 Buchbinder
20160354201 December 8, 2016 Keough
20160361169 December 15, 2016 Gross
20160361184 December 15, 2016 Tabor
20160367364 December 22, 2016 Torrianni
20170000603 January 5, 2017 Conklin
20170000604 January 5, 2017 Conklin
20170035562 February 9, 2017 Qaadri
20170056171 March 2, 2017 Cooper
20170071736 March 16, 2017 Zhu
20170076014 March 16, 2017 Bressloff
20170079786 March 23, 2017 Li
20170079795 March 23, 2017 Morrissey
20170100246 April 13, 2017 Rus
20170112620 April 27, 2017 Curley
20170128208 May 11, 2017 Christianson
20170143488 May 25, 2017 Lashinski
20170143489 May 25, 2017 Lashinski
20170165065 June 15, 2017 Rothstein
20170181851 June 29, 2017 Annest
20170189177 July 6, 2017 Schweich
20170196690 July 13, 2017 Racchini
20170209266 July 27, 2017 Lane
20170216030 August 3, 2017 Joensson
20170224480 August 10, 2017 Garde
20170224486 August 10, 2017 Delaloye
20170231755 August 17, 2017 Gloss
20170231760 August 17, 2017 Lane
20170239047 August 24, 2017 Quill
20170245994 August 31, 2017 Khairkhahan
20170252163 September 7, 2017 Kheradvar
20170258584 September 14, 2017 Chang
20170258585 September 14, 2017 Marquez
20170273784 September 28, 2017 Racchini
20170281337 October 5, 2017 Campbell
20170296340 October 19, 2017 Gross
20170325976 November 16, 2017 Nguyen
20170333184 November 23, 2017 Ryan
20170348099 December 7, 2017 Mendelson
20170348100 December 7, 2017 Lane
20170360558 December 21, 2017 Ma
20170360561 December 21, 2017 Bell
20180035971 February 8, 2018 Brenner
20180042549 February 15, 2018 Ho
20180042723 February 15, 2018 Yellin
20180043133 February 15, 2018 Wong
20180049875 February 22, 2018 Iflah
20180049876 February 22, 2018 Mikraki
20180055628 March 1, 2018 Patel
20180055633 March 1, 2018 Costello
20180056045 March 1, 2018 Donoghue
20180056046 March 1, 2018 Kiersey
20180071088 March 15, 2018 Badhwar
20180078367 March 22, 2018 Saar
20180078368 March 22, 2018 Vidlund
20180078370 March 22, 2018 Kovalsky
20180085219 March 29, 2018 Krivoruchko
20180098837 April 12, 2018 Shahriari
20180099124 April 12, 2018 McLoughlin
20180116843 May 3, 2018 Schreck
20180125642 May 10, 2018 White
20180125654 May 10, 2018 Duffy
20180126127 May 10, 2018 Devereux
20180133000 May 17, 2018 Scheinblum
20180133006 May 17, 2018 Jones
20180133011 May 17, 2018 Perouse
20180140417 May 24, 2018 Sciscio
20180147041 May 31, 2018 Choinard
20180161158 June 14, 2018 Kovalsky
20180161161 June 14, 2018 Yellin
20180168793 June 21, 2018 Lees
20180177580 June 28, 2018 Shemesh
20180177594 June 28, 2018 Patel
20180185153 July 5, 2018 Bishop
20180193138 July 12, 2018 Vidlund
20180200049 July 19, 2018 Chambers
20180214141 August 2, 2018 Mendez
20180221016 August 9, 2018 Conklin
20180243071 August 30, 2018 Eigler
20180243532 August 30, 2018 Willard
20180256322 September 13, 2018 Zhang
20180256327 September 13, 2018 Perszyk
20180280174 October 4, 2018 Dwork
20180289474 October 11, 2018 Rajagopal
20180289475 October 11, 2018 Chung
20180289485 October 11, 2018 Rajagopal
20180296335 October 18, 2018 Miyashiro
20180296337 October 18, 2018 Duhay
20180303488 October 25, 2018 Hill
20180311474 November 1, 2018 Tyler
20180318073 November 8, 2018 Tseng
20180318078 November 8, 2018 Willard
20180325665 November 15, 2018 Gurovich
20180325671 November 15, 2018 Abunassar
20180338832 November 29, 2018 Ganesan
20180353293 December 13, 2018 Colavito
20180353295 December 13, 2018 Cooper
20180360439 December 20, 2018 Niland
20180360599 December 20, 2018 Drasler
20190008640 January 10, 2019 Cooper
20190015188 January 17, 2019 Eigler
20190021834 January 24, 2019 Nir
20190029823 January 31, 2019 Nguyen
20190038404 February 7, 2019 Iamberger
20190038405 February 7, 2019 Iamberger
20190053894 February 21, 2019 Levi
20190053895 February 21, 2019 Levi
20190053897 February 21, 2019 Levi
20190053898 February 21, 2019 Maimon
20190053899 February 21, 2019 Levi
20190060051 February 28, 2019 Scheeff
20190060059 February 28, 2019 Delgado
20190060069 February 28, 2019 Maimon
20190060071 February 28, 2019 Lane
20190070003 March 7, 2019 Siegel
20190076233 March 14, 2019 Fish
20190076249 March 14, 2019 Khairkhahan
20190083085 March 21, 2019 Gilmore
20190091005 March 28, 2019 Fifer
20190091015 March 28, 2019 Dienno
20190091018 March 28, 2019 Hariton
20190091022 March 28, 2019 Yellin
20190099265 April 4, 2019 Braido
20190099270 April 4, 2019 Morrissey
20190105153 April 11, 2019 Barash
20190117223 April 25, 2019 Abunassar
20190117387 April 25, 2019 Li
20190117391 April 25, 2019 Humair
20190117400 April 25, 2019 Medema
20190117401 April 25, 2019 Cortez
20190125287 May 2, 2019 Itou
20190125536 May 2, 2019 Prabhu
20190133528 May 9, 2019 Kassab
20190133756 May 9, 2019 Zhang
20190133757 May 9, 2019 Zhang
20190133765 May 9, 2019 Yellin
20190142566 May 16, 2019 Lansky
20190142582 May 16, 2019 Drasler
20190150867 May 23, 2019 Itou
20190151509 May 23, 2019 Kheradvar
20190167423 June 6, 2019 Hariton
20190167429 June 6, 2019 Stearns
20190175338 June 13, 2019 White
20190175339 June 13, 2019 Vidlund
20190175344 June 13, 2019 Khairkhahan
20190183639 June 20, 2019 Moore
20190183644 June 20, 2019 Hacohen
20190183648 June 20, 2019 Trapp
20190192287 June 27, 2019 Sandstrom
20190192296 June 27, 2019 Schwartz
20190209317 July 11, 2019 Zhang
20190209320 July 11, 2019 Drasler
20190231523 August 1, 2019 Lombardi
20190240020 August 8, 2019 Rafiee
20190240022 August 8, 2019 Rafiee
20190247050 August 15, 2019 Goldsmith
20190254815 August 22, 2019 Bruchman
20190254816 August 22, 2019 Anderson
20190262118 August 29, 2019 Eigler
20190262129 August 29, 2019 Cooper
20190269413 September 5, 2019 Yodfat
20190269504 September 5, 2019 Wang
20190269839 September 5, 2019 Wilson
20190282360 September 19, 2019 Colavito
20190290426 September 26, 2019 Maimon
20190290427 September 26, 2019 Mantanus
20190307563 October 10, 2019 Sandstrom
20190307589 October 10, 2019 Goldberg
Foreign Patent Documents
2006203686 November 2008 AU
2009219415 September 2009 AU
2011238752 October 2012 AU
2011240940 October 2012 AU
2012272855 January 2014 AU
2011236036 June 2014 AU
2011248657 December 2014 AU
2016228261 April 2017 AU
2017210659 August 2017 AU
2013245201 October 2017 AU
2014360294 October 2017 AU
2016249819 November 2017 AU
2016371525 May 2018 AU
2016366783 June 2018 AU
2017214672 October 2018 AU
2017285993 January 2019 AU
2014201920 February 2019 AU
2015411406 February 2019 AU
2019202290 April 2019 AU
2017388857 August 2019 AU
PI0909379 September 2019 BR
2531528 January 2005 CA
2609800 January 2007 CA
2822636 October 2008 CA
2398948 August 2009 CA
2813419 April 2012 CA
2856088 May 2013 CA
2866315 September 2013 CA
2922123 April 2015 CA
2504258 June 2015 CA
2677648 October 2015 CA
2815331 October 2015 CA
2986584 November 2015 CA
2975294 August 2016 CA
2995603 February 2017 CA
2702615 June 2017 CA
2744395 August 2017 CA
2753853 September 2017 CA
3020238 November 2017 CA
3033666 February 2018 CA
3031572 March 2018 CA
3022641 May 2018 CA
3044062 June 2018 CA
3048893 July 2018 CA
3049792 July 2018 CA
3046693 August 2018 CA
2778944 August 2019 CA
2855366 January 2007 CN
100584292 January 2010 CN
101677820 March 2010 CN
101677851 March 2010 CN
102858272 January 2013 CN
102869320 January 2013 CN
102892384 January 2013 CN
103118630 May 2013 CN
103189015 July 2013 CN
103228231 July 2013 CN
103298426 September 2013 CN
103370035 October 2013 CN
103391756 November 2013 CN
102245120 August 2014 CN
104220027 December 2014 CN
102917668 January 2015 CN
104394803 March 2015 CN
104582637 April 2015 CN
102905647 July 2015 CN
103648570 September 2015 CN
104884000 September 2015 CN
104160076 December 2015 CN
105380730 March 2016 CN
105451687 March 2016 CN
105520792 April 2016 CN
105530893 April 2016 CN
102458309 May 2016 CN
103200900 May 2016 CN
105555232 May 2016 CN
105578992 May 2016 CN
103338709 June 2016 CN
105658178 June 2016 CN
105792780 July 2016 CN
103347467 August 2016 CN
103648439 August 2016 CN
103889472 August 2016 CN
105899150 August 2016 CN
103153232 September 2016 CN
106061437 October 2016 CN
106068109 November 2016 CN
106073946 November 2016 CN
106255475 December 2016 CN
103917194 February 2017 CN
106456324 February 2017 CN
106456325 February 2017 CN
105073068 March 2017 CN
106470641 March 2017 CN
105451684 April 2017 CN
106573129 April 2017 CN
103945792 May 2017 CN
106659394 May 2017 CN
106716098 May 2017 CN
106794063 May 2017 CN
106890035 June 2017 CN
106943207 July 2017 CN
106999054 August 2017 CN
106999281 August 2017 CN
104114127 September 2017 CN
107115161 September 2017 CN
107249482 October 2017 CN
107260366 October 2017 CN
104918582 November 2017 CN
107374783 November 2017 CN
107427364 December 2017 CN
106255476 January 2018 CN
107530157 January 2018 CN
107530167 January 2018 CN
107530177 January 2018 CN
107613908 January 2018 CN
104869948 February 2018 CN
107714240 February 2018 CN
107920897 April 2018 CN
104853696 June 2018 CN
108135696 June 2018 CN
108430392 August 2018 CN
108472142 August 2018 CN
106726007 November 2018 CN
109124829 January 2019 CN
109199641 January 2019 CN
109561962 April 2019 CN
109567991 April 2019 CN
109862835 June 2019 CN
109906063 June 2019 CN
109996581 July 2019 CN
110013358 July 2019 CN
110290764 September 2019 CN
102014102648 September 2015 DE
102014102650 September 2015 DE
102014102718 September 2015 DE
102014102722 September 2015 DE
202017104793 November 2018 DE
202016008737 April 2019 DE
2549953 February 2017 DK
2254514 December 2018 DK
027348 July 2017 EA
0902704 March 1999 EP
1684666 August 2006 EP
1996246 December 2008 EP
2211779 August 2010 EP
2254513 December 2010 EP
2263605 December 2010 EP
2273947 January 2011 EP
2296744 March 2011 EP
2379008 October 2011 EP
2400926 January 2012 EP
2427145 March 2012 EP
1582178 September 2012 EP
2542186 January 2013 EP
2558030 February 2013 EP
2560579 February 2013 EP
2575681 April 2013 EP
2603172 June 2013 EP
2637607 September 2013 EP
2651337 October 2013 EP
2658476 November 2013 EP
2699201 February 2014 EP
2405966 April 2014 EP
2055263 June 2014 EP
2741711 June 2014 EP
2793763 October 2014 EP
2822503 January 2015 EP
2538879 April 2015 EP
2444031 July 2015 EP
1702247 August 2015 EP
2772228 November 2015 EP
2943160 November 2015 EP
2470098 December 2015 EP
1991168 January 2016 EP
2254512 January 2016 EP
2964152- 1 January 2016 EP
2964152 January 2016 EP
2967853 January 2016 EP
2967860 January 2016 EP
2994073 March 2016 EP
3001978 April 2016 EP
3003187 April 2016 EP
3007649 April 2016 EP
3010447 April 2016 EP
3017792 May 2016 EP
3019092 May 2016 EP
2563236 June 2016 EP
3027143 June 2016 EP
3037064 June 2016 EP
2211758 July 2016 EP
3052053 August 2016 EP
3060140 August 2016 EP
3062745 September 2016 EP
3071149 September 2016 EP
2282700 November 2016 EP
2967854 November 2016 EP
1998713 December 2016 EP
3099271 December 2016 EP
3100701 December 2016 EP
3141219 March 2017 EP
3157469 April 2017 EP
2538880 May 2017 EP
2967852 June 2017 EP
3174503 June 2017 EP
3182931 June 2017 EP
2830536 August 2017 EP
2830537 September 2017 EP
2720642 October 2017 EP
3232941 October 2017 EP
3256076 December 2017 EP
3281608 February 2018 EP
2608815 March 2018 EP
3310302 April 2018 EP
3311778 April 2018 EP
3337412 June 2018 EP
3340931 July 2018 EP
3344188 July 2018 EP
3344197 July 2018 EP
3345573 July 2018 EP
2822473 August 2018 EP
3354208 August 2018 EP
3370649 September 2018 EP
3372198 September 2018 EP
3372199 September 2018 EP
3375411 September 2018 EP
2928538 November 2018 EP
3399947 November 2018 EP
3400913 November 2018 EP
3406224 November 2018 EP
2555709 December 2018 EP
3417813 December 2018 EP
3426188 January 2019 EP
3429507 January 2019 EP
3431040 January 2019 EP
3432825 January 2019 EP
3432834 January 2019 EP
3437669 February 2019 EP
3448312 March 2019 EP
3454787 March 2019 EP
2663259 May 2019 EP
3302364 May 2019 EP
3478224 May 2019 EP
3484411 May 2019 EP
3487420 May 2019 EP
2560580 June 2019 EP
3508113 July 2019 EP
1301225 August 2019 EP
3518748 August 2019 EP
3522830 August 2019 EP
3528749 August 2019 EP
3288495 September 2019 EP
3538024 September 2019 EP
3538025 September 2019 EP
3019123 October 2019 EP
3508113 October 2019 EP
3552584 October 2019 EP
3552655 October 2019 EP
2369241 November 2011 ES
2647777 December 2017 ES
2664243 April 2018 ES
2675726 July 2018 ES
2539444 December 2016 GB
2003530956 October 2003 JP
2005521513 July 2005 JP
2008506459 March 2008 JP
2008512211 April 2008 JP
2009148579 July 2009 JP
2009525138 July 2009 JP
2009527316 July 2009 JP
2009254864 November 2009 JP
4426182 March 2010 JP
2010518947 June 2010 JP
2010537680 December 2010 JP
2011510797 April 2011 JP
2013503009 January 2013 JP
2013505082 February 2013 JP
2013508027 March 2013 JP
2013512765 April 2013 JP
2013523261 June 2013 JP
2013527010 June 2013 JP
2013543399 December 2013 JP
2014501563 January 2014 JP
2014505537 March 2014 JP
5527850 June 2014 JP
2014518697 August 2014 JP
201422678 September 2014 JP
2015503948 February 2015 JP
2015510819 April 2015 JP
2015517854 June 2015 JP
5767764 August 2015 JP
5803010 November 2015 JP
2015531283 November 2015 JP
2015534887 December 2015 JP
2016503710 February 2016 JP
2016506794 March 2016 JP
2016508858 March 2016 JP
2016517748 June 2016 JP
2016520391 July 2016 JP
2016526438 September 2016 JP
2016530046 September 2016 JP
2016533787 November 2016 JP
2016540617 December 2016 JP
2017000729 January 2017 JP
2017504410 February 2017 JP
2017515609 June 2017 JP
2017516536 June 2017 JP
2017516609 June 2017 JP
2017131738 August 2017 JP
2017159055 September 2017 JP
2017529908 October 2017 JP
2018501001 January 2018 JP
2018501901 January 2018 JP
2018506412 March 2018 JP
6329570 May 2018 JP
2019134972 May 2018 JP
2018515306 June 2018 JP
2018118136 August 2018 JP
2018532556 November 2018 JP
2018535074 November 2018 JP
2019500952 January 2019 JP
2019501696 January 2019 JP
2019501712 January 2019 JP
6466853 February 2019 JP
6480343 March 2019 JP
2019507664 March 2019 JP
6506813 April 2019 JP
6526043 June 2019 JP
2019103821 June 2019 JP
2019514490 June 2019 JP
2019516527 June 2019 JP
2019517346 June 2019 JP
6568213 August 2019 JP
2019523090 August 2019 JP
2019155178 September 2019 JP
2019526303 September 2019 JP
20010013991 February 2001 KR
20120101625 September 2012 KR
101223313 January 2013 KR
101354189 January 2014 KR
20140139060 December 2014 KR
20150097757 August 2015 KR
20160024992 March 2016 KR
177405 February 2018 RU
WO-0044308 August 2000 WO
WO-03072287 September 2003 WO
WO-2004093728 November 2004 WO
WO-2006029062- 1 March 2006 WO
WO-2006066150 June 2006 WO
WO-2007047945 April 2007 WO
WO-2007054015 May 2007 WO
WO-2007095233 August 2007 WO
WO-2007129220 November 2007 WO
WO-2008013915 January 2008 WO
WO-2008091925 July 2008 WO
WO-2008103280 August 2008 WO
WO-2019131148 October 2008 WO
WO-2009081396 July 2009 WO
WO-2009094188 July 2009 WO
WO-2009094189 July 2009 WO
WO-2009094197 July 2009 WO
WO-2009094501 July 2009 WO
WO-2009100242 August 2009 WO
WO-2010029190 March 2010 WO
WO-2018008019 September 2010 WO
WO-2010119110 October 2010 WO
WO-2011112706 September 2011 WO
WO-2011137531 November 2011 WO
WO-2012009558 January 2012 WO
WO-2012063228 May 2012 WO
WO-2012063242 May 2012 WO
WO-2012112469 August 2012 WO
WO-2012145545 October 2012 WO
WO-2012161786 November 2012 WO
WO-2012175483 December 2012 WO
WO-2012178115 December 2012 WO
WO-2013021375 February 2013 WO
WO-2013085719 June 2013 WO
WO-2013103612 July 2013 WO
WO-2013116785 August 2013 WO
WO-2013128436 September 2013 WO
WO-2013148019 October 2013 WO
WO-2013166356 November 2013 WO
WO-2013177684 December 2013 WO
WO-2013184945 December 2013 WO
WO-2014011330 January 2014 WO
WO-2014064695 May 2014 WO
WO-2014121042 August 2014 WO
WO-2014133667 September 2014 WO
WO-2014137805 September 2014 WO
WO-2014140230 September 2014 WO
WO-2014162306 October 2014 WO
WO-2014164151 October 2014 WO
WO-2014168655 October 2014 WO
WO-2015004173 January 2015 WO
WO-2015014960 February 2015 WO
WO-2015017075 February 2015 WO
WO-2015055605 April 2015 WO
WO-2015057735 April 2015 WO
WO-2015058039 April 2015 WO
WO-2015061021 April 2015 WO
WO-2015117025 August 2015 WO
WO-2015120122 August 2015 WO
WO-2015123607 August 2015 WO
WO-2015127264 August 2015 WO
WO-2015142834 September 2015 WO
WO-2015153755 October 2015 WO
WO-2016011267 January 2016 WO
WO-2016025733 February 2016 WO
WO-2016083351 June 2016 WO
WO-2016097337 June 2016 WO
WO-2016100799 June 2016 WO
WO-2016118851 July 2016 WO
WO-2016130913 August 2016 WO
WO-2016149083 September 2016 WO
WO-2016150806 September 2016 WO
WO-2016189391 December 2016 WO
WO-2017040684 March 2017 WO
WO-2017096157 June 2017 WO
WO-2017114928 July 2017 WO
WO-2017120404 July 2017 WO
WO-2017121193 July 2017 WO
WO-2017121194 July 2017 WO
WO-2017121195 July 2017 WO
WO-2017136596 August 2017 WO
WO-2016148777 September 2017 WO
WO-2017151292 September 2017 WO
WO-2017155892 September 2017 WO
WO-2017156352 September 2017 WO
WO-2017165842 September 2017 WO
WO-2017196511 November 2017 WO
WO-2017201082 November 2017 WO
WO-2017202042 November 2017 WO
WO-2017210356 December 2017 WO
WO-2017218375 December 2017 WO
WO-2019006383 January 2018 WO
WO-2018026445 February 2018 WO
WO-2018026904 February 2018 WO
WO-2018035105 February 2018 WO
WO-2018040244 March 2018 WO
WO-2018042439 March 2018 WO
WO-2018045156 March 2018 WO
WO-2018071115 April 2018 WO
WO-2018077143 May 2018 WO
WO-2018077146 May 2018 WO
WO-2018080328 May 2018 WO
WO-2018083493 May 2018 WO
WO-2018090576 May 2018 WO
WO-2018098032 May 2018 WO
WO-2018106460 June 2018 WO
WO-2018119304 June 2018 WO
WO-2018138658 August 2018 WO
WO-2018145055 August 2018 WO
WO-2018156767 August 2018 WO
WO-2018156922 August 2018 WO
WO-2018158747 September 2018 WO
WO-2018160790 September 2018 WO
WO-2018165358 September 2018 WO
WO-2018170149 September 2018 WO
WO-2018175220 September 2018 WO
WO-2018175619 September 2018 WO
WO-2018178208 October 2018 WO
WO-2018178977 October 2018 WO
WO-2018183832 October 2018 WO
WO-2018184225 October 2018 WO
WO-2018184226 October 2018 WO
WO-2018187495 October 2018 WO
WO-2018187753 October 2018 WO
WO-2018191681 October 2018 WO
WO-2018200531 November 2018 WO
WO-2018200942 November 2018 WO
WO-2018201111 November 2018 WO
WO-2018201212 November 2018 WO
WO-2018204106 November 2018 WO
WO-2018209302 November 2018 WO
WO-2018213209 November 2018 WO
WO-2018217525 November 2018 WO
WO-2018222799 December 2018 WO
WO-2018226628 December 2018 WO
WO-2019003221 January 2019 WO
WO-2019010458 January 2019 WO
WO-2019014473 January 2019 WO
WO-2019018319 January 2019 WO
WO-2019023385 January 2019 WO
WO-2019026059 February 2019 WO
WO-2019032992 February 2019 WO
WO-2019037579 February 2019 WO
WO-2019040357 February 2019 WO
WO-2019042472 March 2019 WO
WO-2019046099 March 2019 WO
WO-2019046205 March 2019 WO
WO-2019051168 March 2019 WO
WO-2019051180 March 2019 WO
WO-2019051587 March 2019 WO
WO-2019055577 March 2019 WO
WO-2019058178 March 2019 WO
WO-2019067219 April 2019 WO
WO-2019081689 May 2019 WO
WO-2019081985 May 2019 WO
WO-2019086958 May 2019 WO
WO-2019089136 May 2019 WO
WO-2019089821 May 2019 WO
WO-2019093387 May 2019 WO
WO-2019095049 May 2019 WO
WO-2019096033 May 2019 WO
WO-2019099722 May 2019 WO
WO-2019116322 June 2019 WO
WO-2019119674 June 2019 WO
WO-2019126518 June 2019 WO
WO-2017161204 July 2019 WO
WO-2019136162 July 2019 WO
WO-2019140293 July 2019 WO
WO-2019143775 July 2019 WO
WO-2019144036 July 2019 WO
WO-2019147585 August 2019 WO
WO-2019165213 August 2019 WO
WO-2019173475 September 2019 WO
WO-2019190800 October 2019 WO
WO-2019191102 October 2019 WO
Patent History
Patent number: 10595994
Type: Grant
Filed: Jun 10, 2019
Date of Patent: Mar 24, 2020
Assignee: VDYNE, LLC (Maple Grove, MN)
Inventors: Mark Christianson (Plymouth, MN), Robert Vidlund (Forest Lake, MN), Neelakantan Saikrishnan (Plymouth, MN)
Primary Examiner: Diane D Yabut
Application Number: 16/435,687
Classifications
Current U.S. Class: Supported By Frame (623/2.17)
International Classification: A61F 2/24 (20060101); A61L 27/36 (20060101); A61L 31/02 (20060101); A61L 31/12 (20060101); A61F 2/91 (20130101); A61L 31/00 (20060101); A61L 31/14 (20060101); A61F 2/06 (20130101);